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Serum Procalcitonin As A Diagnostic Marker Of Bacterial Infection
In Febrile Children
ABSTRACT
Febrile illnesses are the most common cause for seeking health
care in pediatric age group. Often children do not have classical signs and
symptoms. In the past, various biomarkers have been evaluated with
varying degree of sensitivity and specificity in diagnosing bacterial
infections. This study aims at ascertaining whether serum procalcitonin
(PCT) is able to accurately diagnose bacterial infection among febrile
children.The study also attempts to compare the test characteristics of
PCT with C –reactive protein (HsCRP) and absolute neutrophil count
(ANC). Among the three parameters studied, PCT emerged as a highly
specific marker (84.16% specificity), negative predictive value of 89%
with an area under curve in ROC (receiver operating characteristic curve)
of 0.755. Thus, we would like to postulate that PCT can be used as a
single best marker to diagnose bacterial infection in febrile children when
used in isolation.
Key words
Procalcitonin, Hs-CRP, absolute neutrophil count,febrile children,
antibiotic resistance ,bacterial infection
INTRODUCTION
Acute febrile illness is the most common cause for seeking health
care as far as children are concerned. Children do not have definite
localizing  signs  at  the  time  of  presentation.  Even  if  there  is  some
localization, it is not possible to differentiate bacterial infection from viral
infections based on subtle clinical signs alone 1. The routine lab
investigations on which we rely upon do not entirely differentiate serious
bacterial infection from others.
A short overview of certain terminologies is as follows:
Infection:
The invasion of microorganisms and their toxins into normally
sterile places, a microbial phenomenon characterized by a definite
inflammatory response by the host immune system.
Fever:
It is defined as increased body temperature because of the “reset”
of the thermoregulatory mechanism by the hypothalamus. This occurs
because of the induction of the host immunity by the cytokines namely
INF, IL 6, IL1, TNF etc.
Bacteremia:
Presence of viable bacteria in the host circulating system
         In the era of evidence based medicine, definitive treatment like
initiating antibiotics needs confirmatory evidence. But waiting for
confirmatory reports like culture (blood, urine) is time consuming
especially in sick children in whom delay of appropriate treatment can be
detrimental. Added to that, most of the time physicians are faced with the
difficult  task  of  choosing  among  a  variety  of  diagnostic  tests that are
available for the diagnosis of infections in children2.
A lot of research goes on every year and new tests, for example,
those tests based on the polymerase chain reaction3 (PCR), are
increasingly becoming available thereby adding on to the confusion.
Many physicians are generally not very familiar with the difficulties in
choosing from among the tests and the limitations of many laboratory
assays. The interpretation of such test results often changes with
reference  to  the  age  of  the  patient  and  the  clinical  condition.  In  the
clinical sense, a test employed in the diagnosis, must be timely and cost-
effective.
It also must possess appropriate sensitivity and specificity, and the
results of that particular test, when they become available, should have a
certain amount of impact on the clinical management of the patient’s
given clinical problem.
The  treating physician should be well familiar with the correct
techniques for obtaining the sample and also in the transportation of the
clinical sample, and in the interpretation of the given results in view of
the sensitivity and specificity of that particular assay. On the other hand,
indiscriminate use of antibiotics leads to antibiotic resistance4
Hence it is high time that we use a biomarker which can reliably
differentiate bacterial from other infections, but with acceptable
sensitivity and specificity.5
In practice, bacterial infections account for 5–25% of febrile
illnesses in the pediatric population. The pediatric population hardly
shows any localizing signs of infection systemically even in life
threatening bacterial infections. It is indeed a big responsibility for the
physicians in making an accurate diagnosis of the illness in febrile
children and to triage the children who are likely to develop serious
complications. Mean while, since children have only self limiting viral
illnesses most commonly, care should be taken that they should not be
subjected to over investigation and/ or overtreatment.
In the year 2001, the National Institutes of Health (NIH) convened
a panel in order to develop standard definitions and a conceptual
framework for the discovery of biomarkers and their incorporation into
the clinical management .
Based on this consensus definition,   a biomarker is broadly
defined as follows:
“Biomarker”  is  a characteristic which can be objectively measured
and also evaluated as an reliable indicator of normal biological processes,
pathological processes, and/ or pharmacological responses to given a
therapeutic intervention. Based on this, biomarkers can be subdivided
into two groups,
? “Type 0”   and
? “Type 1”
Type – 0 biomarker:
A Type 0 biomarker gives a picture of the natural history of the
disease process which   correlates with that particular disease in
longitudinal manner with known clinical indices & outcomes.
Type 1 biomarker:
A Type 1 biomarker gives a picture of the effects of a therapeutic
intervention provided to treat the disease  according to its mechanism of
action.
            “NICE traffic light system”6 which has been used in diagnosing
common bacterial infections has moderate sensitivity but has low
specificity in febrile young children. It is used in the detection of
common infections namely pneumonia, bacteremia & urinary tract
infections.  Many  a  time’s  sepsis  is  a  close  differential  diagnosis  of
Systemic Inflammatory Response Syndrome (SIRS), especially in very
sick children. The differentiation of sepsis from SIRS necessitates a
thorough clinical knowledge.
Etiology of SIRS:
SIRS can be of two types:
1) Infectious
2) Non infectious
1) Infectious causes of SIRS
? Infections caused by bacteria (pneumonia), viruses, yeasts etc.
? Erysipelas, Influenza
? Infective endocarditis, meningitis, pyelonephritis, appendicitis,
cholecystitis, cellulitis, arthritis etc.
2) Non- infectious causes of SIRS
? Trauma
? Burns
? Acute pancreatitis
? Poisoning etc.
Sepsis:
SIRS with a documented or suspected infectious etiology
                   Often distinguishing SIRS (Systemic Inflammatory Response
Syndrome) 7,8  from  sepsis  can   be  a  difficult  endeavor  since  there  is  a
criteria for “infection”.  Though infection can be suspected as early as
possible at the time of presentation in a given clinical scenario, time
duration of 24–48 hours is essential before that suspicion can be
confirmed or definitively ruled out by laboratory tests. SIRS can be
triggered by a spectrum of non-infectious causes including trauma,
transplant rejection, burns, autoimmune/ inflammatory disorders,
pancreatitis, graft-versus-host disease etc.
In this particular scenario, “Biomarkers” can be used in the
diagnosis, monitoring and to predict the prognosis or the treatment
outcome. For many decades, C-reactive protein, which is elevated in
inflammatory and infectious conditions, was used as a biomarker
indicating infectious conditions worldwide.
SIRS can be diagnosed by the clinical criteria proposed below:
Definition of systemic inflammatory response syndrome 7,8
The presence of at least two of the following four criteria, one of
which must be abnormal temperature or abnormal leukocyte count
? Core temperature of  >38.5°C or <36°C
? Tachycardia, defined as a mean heart rate >2 SD above normal for
age  in  the  absence  of  external  stimulus,  chronic  drugs  or  painful
stimuli; OR unexplained persistent elevation over  0.5–4 hour time
period; OR in children <1year of age persistant bradycardia,
defined as a mean heart rate <10th percentile for age in the absence
of external vagal stimulus, ?-blocker drugs or congenital heart
disease; OR otherwise unexplained persistent depression over a 0.5
– 1hour time period.
? Respiratory rate >2 SD above normal for age or mechanical
ventilation for an acute process not related to underlying
neuromuscular disease or the receipt of general anesthesia
? Leukocyte count elevated or depressed for age (not secondary to
chemotherapy induced leukopenia) or >10% immature neutrophils.
Even after the use of these clinical criteria, the diagnostic dilemma
in differentiating SIRS and sepsis is confounded by the fact that most of
the time, those conditions are similar to infectious conditions in their
mode of presentation and predispose children to secondary bacterial
infections .  In such situations,  the use of  biomarkers has the potential  to
help differentiate between the two conditions8,9.
Infection is defined as the laboratory documentation of a
pathogenic organism by positive culture, tissue staining or PCR test, or a
clinical syndrome which is associated with a high probability of infection.
Secondly, this differentiation between SIRS and sepsis, is a very
essential one from one point as it needs adequate treatment, such as the
initiation, selection of appropriate drugs and as a guide in the duration of
antibiotic therapy. For the same reason, clinical management guidelines
focus  primarily  on  physiologic  parameters  of  well  being  such  as
hemodynamic indices, blood oxygen saturations and signs of end organ
perfusion.
These indicators give an overall picture of patient status, but they
are inadequate in providing accurate real time assessments of the
underlying disease condition and they also do not provide essential
information for prognostication.
What are biomarkers?
         In  2001,  the  definition  of  biomarkers  was  put  forth  by  the  NIH
special panel. They broadly defined biomarkers as any “characteristic that
is objectively measured and evaluated as an indicator of normal
biological processes, pathogenic processes, or pharmacologic responses
to a therapeutic intervention.” Over the years, so many diagnostic
markers for sepsis have been described in literature 8,9. There are four
general types described in recent literature, namely:
? Diagnostic markers
? Monitoring markers
? Stratification marker and
? Surrogate biomarkers
Diagnostic biomarkers:
Diagnostic biomarkers help to establish the presence or absence of
a disease state or other clinical condition.
Monitoring biomarkers:
Monitoring biomarkers consist of a group of molecules or proteins
that have dynamic variation in the levels, as the disease process evolves
or in response to therapeutic interventions. Thus, the medical professional
can track the course of disease and can have an ongoing assessment of the
adequacy of treatment.
Stratification biomarkers:
Stratification biomarkers are used in the assortment of a group of
patients into different varieties  based on  the disease severity with the
intention  of applying treatment to groups of patients who will benefit
most at the least risk.  Stratification biomarkers are used to predict
outcome of a disease process rather than follow its course or to titrate
therapy.
Surrogate biomarkers:
Surrogate biomarkers serve as proxy end points for severe or rare
patient centered outcomes such as death or significant complications.
Various biomarkers and their evolution:
Initial studies employed fever and increased leukocyte counts to
define sepsis but these tests were nonspecific10. Subsequently, researchers
concentrated on erythrocyte sedimentation rate (ESR) and C - reactive
protein (CRP) which is also not very specific in diagnosing bacterial
infection9,10. As we know, sepsis provokes a systemic host immune
response inside the body. The knowledge of using the multiple mediators
that can be used as biomarkers for both the diagnosis and prognosis of
infection became popular. Till date, totally around 180 biomarkers have
been evaluated for the same. They include IL-6, lactate, IL-8, soluble
triggering receptor which are expressed on myeloid cells-1 (strem-1), and
procalcitonin (PCT)11. Procalcitonin has been studied in detail among the
other markers, and is supposed to be a promising one.
The use of Biomarkers, on the other hand is supposed to reduce the
antibiotic use worldwide9,10,12.  This  in  turn  can  reduce  the  burden  of
antibiotic resistance especially in the growing world which has
indiscriminate antibiotic usage. India, with population of 1.2 billion, is
documented to have one of the highest infectious disease burdens in the
world. Due to this alarming rise of drug resistance, biomarkers that help
with antibiotic stewardship are needed. Various biomarkers which are
used in the infectious conditions are detailed below:
1) Leucocyte count:
             Initially, infection was defined by the abnormalities in vital signs
and abnormalities in the leukocyte count. But it was found that both
leukocyte count & relying on immature forms have low positive and
negative predictive values10. Also, leukocytosis, was well recognized with
noninfectious conditions as well. Hence we do not entirely depend on
total leucocyte count as a marker for infection.
2) CRP:
        CRP is an acute-phase reactant. It is produced only by the
hepatocytes in response to any sort of inflammation or tissue injury. The
production  of  CRP  is  induced  by  cytokines  (IL-1,  IL-6  and  TNF-?)  in
response to infection. Serum levels of CRP increase within 4–6 h of an
inflammatory stimulus. The concentration of CRP doubles approximately
every 8 h from the infectious or inflammatory stimulus and finally peaks
at around 36–50 h. It has a very short half life of 4–7 hours 4,9,13.
The median concentration of CRP is below 0.8mg/l and can
increase 1,000-fold in healthy young adult volunteer blood donors
in response to an acute phase stimulus, Hepatic synthesis of CRP starts
rapidly after a stimulus. Since the hepatic synthesis determines the serum
concentration, the half-life of CRP is constant under all conditions 4,13.
In pediatric studies, CRP was used in identifying the neonates who
have sepsis with non specific clinical signs. It can also be used in other
clinical scenarios to distinguish infection from inflammation. It was
concluded that using CRP alone lacked the specificity 10,11,13 essential for
the discrimination of  bacterial, viral and other noninfectious
inflammatory conditions.
Due  to  its  poor  specificity,  CRP  is  often  combined  with  other
biomarkers as part of test panel to assist in the diagnosis of sepsis. CRP
can also be used to monitor treatment response once an infectious
diagnosis has been established. Most of the recent literature regarding
CRP has compared its diagnostic accuracy in diagnosing bacterial
infection with that of newer biomarkers, especially the one most spoken
of i.e. Procalcitonin (PCT).
3) CD 64:
        CD64  is  a  biomarker  expressed  on  the  surface  of  the  neutrophils,
known as fc?r1. CD64 is one of three receptors on the surface of the
neutrophils, whose function is to bind to the fc portion of
immunoglobulin (IgG) and thus facilitating opsonization and
phagocytosis of the bacteria. CD64 is constitutively expressed at low
levels upon the neutrophils. When the immune system encounters an
infectious pathogen, the expression of CD64 is highly up regulated. This
increased    levels  of  CD64  expression  is  measured  by  flow  cytometric
analysis in the blood samples.
In pediatrics, CD64 has been investigated primarily in the setting
of neonatology where it has been used to identify premature and term
neonates presenting with sepsis.  For the pediatric studies, it was found to
have  a  mean  sensitivity  of  71%  and  also  a  mean  specificity  of  87% 11.
Some  of  these  studies  compared  CD64  with  CRP  or  PCT.  The  results
were conflicting in judging as to whether or not CD64 was a significantly
better biomarker. Finally it was concluded that CD64 appeared to be a
good marker of infection, across all subgroups when compared with CRP.
Importantly, it has to be noted that the methodological quality of the few
available studies was poor .
4) Lactate:
            Serum lactate level is another important biomarker in sepsis,
which can be used to distinguish sepsis from septic shock. It is also used
in predicting the prognosis of children who are complicated by septic
shock. In the past, tissue hypoxia was indicated by serum lactate level.
The reduction of serum lactate is accepted as a target for therapeutic
interventions in the treatment of septic shock.
Majority of researches with serum lactate have been conducted in
adults rather than in the pediatric population where it was concluded that
serum lactate was increased in patients with sepsis and patients with
increased levels were sicker and had high mortality11. So, the reduction of
serum lactate is recommended as a target for therapeutic interventions.
5) IL – 18:
              IL – 18 is a cytokine produced by the activated macrophages
participating in the induction of cell-mediated immunity. Literature on
1L-18 is very contradictory11. Kingsmore et al, used a high – throughput
proteomic immunoassay for the measurement of IL-18 and they, reported
that IL-18 is elevated in preterm infants who develop signs and symptoms
of sepsis. In another study by Bender et al., they concluded that in
neonates IL-18 has diagnostic ability. More research is needed to clarify
the utility of this biomarker in the diagnosis and the treatment of sepsis.
Other biomarkers under investigation:
              These include novel and interesting markers such as IL-8,
CD163, high mobility Group protein b1, urokinase-type plasminogen
activator, soluble triggering receptor expressed on myeloid cells and
macrophage migration inhibitory factor, etc.
In this current scenario, serum procalcitonin   is being used
increasingly and is gaining in its application worldwide in the
management of infective conditions.
PROCALCITONIN
                               Schematic representation of procalcitonin
Procalcitonin (PCT), the precursor of the hormone calcitonin which
is  produced  by  the  C  cells  of  the  thyroid  gland,  is  made  of  116  amino
acids. The normal serum level of procalcitonin is <0.05ng/ml, sometimes
it is even undetectable in serum. Half life of procalcitonin is 25-30 hrs in
the absence of antibiotic treatment.14 It is not affected by renal failure,
liver failure etc. For some time, it has been recognized that PCT levels
are increased in children with sepsis and bacterial infection. Under
normal conditions, the thyroid gland is the only tissue that produces PCT
and serum levels are very low. Although the exact proximal stimuli that
mediate PCT secretion are unknown, evidence suggests that early
inflammatory signals such as TNF-?, IL-1? and IL-6 play a role.15,16
Serum levels are increased in response to pro inflammatory stimuli
i.e. bacterial endotoxins by the induction of calc-1 gene expression. There
after procalcitonin rises in the serum within 2-3 hours of induction. The
rate of rise is 0.5ng/ml and plateau is attained in 6-12 hours. With the
initiation of appropriate antibiotic therapy, the level of procalcitonin falls
to the baseline within 48hours of treatment. Assicot et al. demonstrated
that the site for production of procalcitonin during inflammatory
processes can either be the liver or the lungs.
In vitro studies were carried out using various cells, namely,
monocytes, endothelial cells, polymorphonuclear cells and macrophages,
which were stimulated with endotoxin following which the production of
procalcitonin was studied. The pattern of its production  is in the similar
manner as that of some components of the cytokine cascade activation
system, and  some markers involved in the activation of  cellular
immunity13,15.This observation  suggests that  procalcitonin  is   an acute-
phase inflammatory  reactant.
In the animal studies, a trial administration of a supra physiologic
amounts of procalcitonin caused an increased mortality in experimental
sepsis  in  an  animal  model.  On  the  other  hand,  prophylactic  and
therapeutic immune blockade of the pathway of procalcitonin secretion
using multiregion -specific goat antiserum reactive to procalcitonin
resulted in increased survival.
         In neonates, Procalcitonin is a good marker for detecting sepsis.
Increased levels of procalcitonin were found in all neonates with bacterial
sepsis, whereas babies with viral infection or bacterial colonization had
normal levels or only slightly increased levels which were insignificant.
In  the  diagnosis  of   early-onset   sepsis,  procalcitonin  levels  has  a
sensitivity of 92.6%  and specificity of 97.5%14 which is acceptably good
compared to all other biomarkers used in the newborn period.
          Estimation of serum procalcitonin is helpful in differentiating
infection from autoimmune diseases with active disease process. In such
children, procalcitonin can serve as an important tool because patients
with autoimmune diseases are prone to serious infection, particularly
under conditions of iatrogenic immunosuppression.
              For  all  of  the  above  advantages,  procalcitonin  can  be  used  as  a
sensitive marker for diagnosing bacterial infection in children presenting
with acute febrile illness without localizing signs. It can also be used as a
prognosticating marker for guiding antibiotic treatment17. Additionally,
when the patient responds appropriately to therapy, PCT levels return to
normal much quicker than CRP.
Simon  et  al. measured PCT and CRP levels in 64 children who
developed SIRS and compared values between those with a positive
confirmation of infection and those without. Those with confirmed
infection (sepsis) had significantly higher PCT values than those without
(SIRS only), but CRP levels did not differ between the two groups. The
area under the curve for PCT in that study was 0.71 versus 0.65 for
CRP13.
Arkader et al. demonstrated that in children with sepsis, serum
PCT concentration was significantly high  above that of non infected
children with SIRS following cardiopulmonary bypass surgery  which
had (AUC: 0.99). In this setting, however, CRP could not distinguish the
two states,namely sepsis and systemic inflamatory response syndrome
(AUC: 0.54). In a group of 359 children cared for in a pediatric intensive
care unit, Rey et al. showed that PCT was much more superior to CRP in
distinguishing six classes of patients: those without SIRS or sepsis; SIRS
alone; localized  infection; sepsis; severe sepsis; and septic shock and the
definitions of each class is well defined in the study. Procalcitonin  levels
were significantly high with respect to  the severity of illness (AUC:
0.91), but CRP failed to detect the trend of the response to treatment as
good as procalcitonin (AUC: 0.75).
The literature search regarding the use of procalcitonin for the
children who had burns and in whom sepsis was suspected was made.
Only very few studies have been conducted regarding the use of
procalcitonin in burns children.
As burns also triggers an inflammatory response, sometimes as
severe as SIRS, the use of reliable biomarker is needed for the same.
Neely et al in 2004 studied  the use of procalcitonin as an early marker of
sepsis in pediatric burns. Though the definition of sepsis was not defined
in  a  clear  manner  in  this  study,  their  results  showed that  the  cut  off  for
procalcitonin in the diagnosis of bacterial infection is same as for general
population.
          Serial measurement of PCT levels has also been used as a
monitoring biomarker to direct and limit antibiotic usage. The purpose of
this application is to reduce bacterial antibiotic resistance as well as
patient-centered side effects such as nephrotoxicity and drug reactions17.
In the past procalcitonin had limited usage in pediatrics.
To date, there has been no single biomarker discovered that offers
clinicians, caring for sick children, the absolute diagnostic ability to
distinguish sepsis from other inflammatory 18,19disorders or to monitor
and predict its progression or response to treatment.
Likewise, markers for septic shock are inadequate and limited in
their utility. It is unlikely that any single biomarker will be able to predict
with complete certainty the presence or absence of a disease or of a
specific outcome.
All biomarkers must be used in their appropriate clinical context as
adjuncts to the decision-making process. That being said, however, the
use of serum PCT levels appear to be a significant improvement over
CRP that has traditionally enjoyed broad historical usage.20 PCT has been
shown, to our satisfaction, to improve the ability of clinicians in
diagnosing, monitoring and predicting outcome in both sepsis and septic
shock.
AIMS AND OBJECTIVES
AIM OF THE STUDY
? To determine the role of serum procalcitonin as a diagnostic
marker of bacterial infection in febrile children.
OBJECTIVES
? To ascertain the possible diagnostic role of procalcitonin in
differentiating bacterial from viral infections in febrile children.
? To compare serum procalcitonin with hs CRP levels and ANC in
order to identify the more sensitive and specific indicator of the
two.
REVIEW OF LITERATURE
REVIEW OF LITERATURE
This study aims at finding out as to whether procalcitonin can be
used as a marker for diagnosing acute bacterial infection in febrile
children and to compare it with Hs-CRP to find the more sensitive/
specific marker among the two.
The procalcitonin level in serum was found to be closely related to
severe invasive bacterial infection and SIRS. When the infection is loco-
regional or confined to a single organ in the absence of systemic response
of the inflammatory reaction, the procalcitonin is low or only moderately
increased. It also remains low in viral infection. Several studies were
made in the past, determining the effect of serum values of Procalcitonin,
Hs CRP and absolute neutrophil count (ANC) both singly and in
combination18-24. Based on these, some of the biomarkers are included in
the algorithm used in sepsis management.25
Procalcitonin:
            In 1993, Assicot et al26 studied the use procalcitonin in
differentiating viral and bacterial meningitis. They found that
Procalcitonin in serum increases in bacterial meningitis. Their study
yielded a sensitivity of 99% and a specificity of 100%. In 1994, Dandona
et al27 documented an increase of procalcitonin levels in the sera of
normal individuals after injecting endotoxin. Thus, they concluded that
the level of PCT rises with septicemia and in normal subjects this does
not  occur.  In  1999,  Vialon  et  al  studied  the  same  effects  of  the  rise  of
procalcitonin in adults with meningitis. They also found that serum
procalcitonin rises in adults with meningitis and this supports the
observation made by Assicot et al.
Craig  et  al28 initially studied the diagnostic value of clinical
symptoms and signs in the diagnosis of bacterial infection in young
children with fever. According to his study, the diagnosis of bacterial
illness  by  the physicians had a very low sensitivity  (10-50%)  but  high
specificity (90-100%). Several important red flags were identified in the
diagnostic value of presenting clinical features in identifying serious
infections in children.
Use of symptoms and signs alone often resulted in uncertainty in
the diagnosis with the risk of under diagnosis of severe infections. Thus,
the biomarkers are essential for the reliable distinction of bacterial
infection. They also help in decisions to admit or not, to start antibiotics
or not and also when to stop or change. The concentration of serum PCT
sensitive enough to diagnose bacterial meningitis was studied by Jereb et
al29 in 2001. They found the predictive value of procalcitonin in CSF and
serum  to  be  >0.5ng/ml  as  reliable  cut  offs  with  high  PPV  and  NPV,  in
relation to bacterial meningitis. In the same year, Giamarllos et al30,
evaluated the role of procalcitonin as a diagnostic marker in children with
febrile neutropenia . From their study, they concluded that values more
than 2 ng/ml indicate definite evidence of systemic infection.
In the newborns, procalcitonin is supposed to be a reliable tool in
differentiating bacterial and viral infection. Controversy exists in the
literature as it whether procalcitonin or Hs CRP is a best tool in the
detection of newborn sepsis. Some authors demonstrated that
procalcitonin lacked sensitivity and specificity in within the newborn age
group.
This might be due to the fact that procalcitonin can have variable
kinectics in the perinatal period. There is a physiological surge of serum
procalcitonin approximately 24 hours of life which returns to normal after
third day of life. Hence there are age related nomograms developed for
preterm babies.
In  2001,  Connor  et  al31 first described the use of PCT in the
prognostication of bacterial infection. They also found that PCT
differentiates infectious causes of SIRS from non infectious causes which
are very essential from the treatment point of view. In 2003, Colombier et
al used quantitative measurement of PCT values for the diagnosis of
bacterial infection. They concluded that PCT values more than 1.2ng/ml
is definitely associated with bacterial infection and thus it can be used to
guide the antibiotic therapy in hospital settings. Mirjanichrist et al, in
2004, did a study incorporating the role of PCT in the etiologic diagnosis
of lower respiratory tract infection. They described the role of PCT as a
diagnostic marker in lower respiratory tract infection, thereby reducing
antibiotic abuse and suggested the use of a PCT based algorithm in
guiding antibiotic treatment.
In  2005,  Oberhoffer  et  al32 studied the role of biomarkers in
infectious states. The study was done to predict the outcome by the
traditional and new markers of inflammation in patients with sepsis. They
concluded that PCT appears to be a more accurate marker than its
counterparts namely, hs-CR, counts, temperature etc. among the other
markers of inflammation.
The role of PCT and its kinetics, were studied by many authors. In
2005, Yukioka et al33 concluded  that  PCT  is  the  earliest  marker  to  rise
and the level of  rise indicates the severity of infection. Authors then
began investigating the out performance of PCT compared to other
inflammatory markers.
In 2006, David Herd et al34 carried  out  a  study  in  children
presenting with fever, in which it was noted that though PCT can be used
to differentiate bacterial from other illnesses, he concluded that PCT,
when used alone is not a very sensitive indicator. Dauber et al35 in 2008,
stated that although PCT values show mild increase in vaccinated
children, it can still be used to differentiate this from infectious causes of
fever. In the same year, Maniaci et al36 studied the role of PCT in young
children and concluded that in young babies, who often do not have
localizing signs, PCT can be used to detect occult bacterial infection.
Baer et al37 in 2010, compared CRP and other biomarkers and found that
PCT emerged as a single best marker in the molecular diagnosis of sepsis.
Schutz et al in 201138, investigated the use of PCT based algorithm in the
diagnosis and treatment of various diseases. They found that PCT
determination, as a guide, reduces the use of antibiotics considerably.
Thus in end of the previous decade the use of procalcitonin became
widespread worldwide in diagnosing bacterial infections though data is
limited as far as our country is concerned. In a study conducted by
Micheal Baer et al, in 2010, they foung PCT is the best biomarker among
all  the  available  biomarkers  currently  which  was  in  othedies.  The  study
group concluded that this algorithm is useful in severe sepsis, post
operative infections and severe sepsis.
In the Cochrane review, 2012,  on the role of  PCT to initiate or  to
discontinue antibiotic treatment, it was concluded, there is no increased
mortality, and in turn there is a significant reduction of antibiotic
consumption.
Hs-CRP and Absolute neutorphil count(ANC)The  role  of  hs-CRP  in
bacterial or viral infection is well known but it does not differentiate
bacterial infections from other infections. It rises in other inflammatory
conditions as well. CRP is known to rise in non inflammatory conditions
as well. Derek et al 39 in 2000, tried to correlate the concentration of CRP
with adiposity in children. The study showed a strong correlation of CRP
with adiposity in children with a statistical significance of P <0.0006. In
2003,  Prat  et  al  ,  evaluated  the  role  of  CRP,  TLC  and  PCT  in  lower
respiratory tract infection in children.
They also concluded from the study that PCT showed a positive
correlation with the etiology of respiratory tract infection when it was due
to bacteria. Both CRP and procalcitonin show high sensitivity for
distinguishing pneumococcal etiology from other infective etiologies.
Among both, PCT shows a higher specificity than CRP. This was further
supported by Gendrel et al40 who investigated the relation between
procalcitonin and CRP and INF& IL 6.PCT >1 mg/l is more sensitive and
specific compared to CRP, IL-6 and INF. Brauner et al in 200941, studied
the role of leucocyte count in predicting bacterial infection. It was found
that elevated WBC counts >25,000 cells were associated with serious
infections in the 3 – 36mo age group, most commonly pneumonia.
Similarly, in another study by, Ayazi et al in 422009, they studied the
diagnostic accuracy of ANC and CRP in diagnosing bacterial illness.
ANC and CRP were neither specific nor sensitive in diagnosing
bacterial infection of urinary tract. Recently in 2014, Elemraid et al
studied inflammatory markers in diagnosing the etiology of pneumonia.
Bacterial pneumonia had high CRP >80mg/L and levels <20 mg/L were
inconclusive in finding the etiology.
Ann Van den Brue et al in 2011, studied the diagnostic accuracy of
the tests in identifying bacterial illness.WBC counts are not useful in the
diagnosis of bacterial illness. They also suggested the use of different cut
off values for ruling out or ruling in the infections. In the review study
and meta analysis done by Simion et al, comparing PCT and Hs-CRP
levels as a marker of bacterial infection, PCT was concluded to be a more
sensitive and specific marker than Hs-CRP in diagnosing bacterial
infection.
           The evidence for PCT turning into the best among the biomarkers
identified is increasing. Rui-ying Xu et al43, in 2014, analysed the
diagnostic accuracy of procalcitonin  and C-reactive protein in diagnosing
the degree of renal involvement. PCT values were raised with more
severe degree of renal involvement and the CRP did not correlate with the
degree of renal involvement.
            Among the other predictors of bacterial infections, total and
absolute leucocyte count deserves a special mention. Al-majali et al44, in
2004, in children of age 1-18 months with fever, studied the relationship
between white blood cell and  absolute neutrophil count. They arrived at
a conclusion that ANC predicts bacterial infection accurately in young
children with fever without focus.
Saskia et al in 201345, studied the characteristic features of serum C
reactive protein and procalcitonin measurements along with symptoms
and signs in the diagnosis of pneumonia. They also found that adding
CRP concentration >30 mg/l has diagnostic value but procalcitonin
values does not correlate with diagnosis of pneumonia clinically.
In 2001, Moulin et al46, found that PCT values, with a threshold of
1 ng/ml has high sensitivity and specificity and PPV and NPV than CRP,
IL  6,  and  WBC  in  the  differentiation  of  bacterial  pneumonia  and  viral
pneumonia.
Chia-hung Yo et al47, in 2012, concluded that procalcitonin can be
used for ruling out bacterial infection than for ruling in the same. They
also found that though there is a lot of data on procalcitonin, prevailing
evidence does not show how procalcitonin can be combined with other
clinical data.
In  the  same  year,  Nabulsi  et  al48, studied the evidence-based
decision-making in  bacterial illness by CRP. They also suggested better
quality research is essential for the definitive determination of the
diagnostic accuracy of CRP levels in children.  The present evidence for
CRP in children with bacterial infection is weak and has low diagnostic
value.
PCT for Antimicrobial Stewardship
Due to its ability to help differentiate between viral and bacterial
infections, PCT has been evaluated for its ability to guide decisions for
appropriate antibiotic therapy.
India has one of the highest rates of infectious diseases and has
alarmingly high rates of resistant bacteria, making utilization of
diagnostics that help indicate when unnecessary antibiotics can be
avoided, as a prime goal.
The PRORATA trial, a multicenter, prospective, open-label, and
randomized control trial including 621 patients in 8 ICUs in 6 hospitals
followed these smaller studies and found a 23% reduction in antibiotic
usage at day 28. There are a lot of studies in literature showing the rising
antibiotic resistances in the community, especially in a growing country
like India though the pediatric studies are limited. There are a lot of
working group formulated algorithms including diagnostic parameters in
the initiation of antibiotic treatment to reduce drug resistance.
In 2005, Oosterheert et al49 studied whether increased diagnostic
modalities can overcome the problem of antibiotic resistance. Utilization
of RT- PCR for the etiological diagnosis of lower respiratory tract
infection, increased the diagnostic accuracy, but antibiotic use was
unaltered. In 2007, Mohammed Akram et alwhile studying the resistance
pattern of  bacteria in India, studied  an increasing resistance to co-
trimoxazole  and production of extended spectrum ?-lactamase among the
bacteria causing UTI in the community.
D Raghunath et al12 in 2008, suggested the development and
evaluation of improved diagnostic methods for diagnosing bacterial
infection. As per Global Antibiotic Resistance Partnership (GARP) -
India working group*- current antibiotic trend in India’s suggests
increasing the use of diagnostic tests as one of the measures to reduce
antibiotic usage and resistance.
As per our recent evidence, Adnan Mannan et al50 in 2014, studied
bacterial resistance patterns in India, 64.2% of S. typhi were multidrug
resistant. Thus, it is high time we cut down the antibiotic consumption
based on evidence based medicine. In 2014, Nelson et al5 reviewed sepsis
biomarkers with special reference to the Indian scenario. PCT ay be used
as a tool in the sepsis algorithm. It also lessens dependence on
microbiology resources in India.
This picture illustrates the increasing use of antibiotics in India21.
The volume of consumption of antibiotics has also increased from 2005
and is still on the increasing trend. Also, the rate of use of higher
antibiotics can be increasingly noted. This is because of the increase in
the resistance pattern of the pathogens causing bacterial illness to the
common drugs51. This alarming increase in drug resistance could be
partly due to the inadvertent and indiscriminate antibiotic usage by the
medical professionals 52,53.  Though there are many reasons for this trend
of antibiotic prescription, like lack of knowledge for choosing an
appropriate drug for the particular disease, one of the main reasons could
be lack of appropriate diagnostic skills54.
The use of RT-PCR for diagnosing respiratory pathogens causing
lower respiratory tract infections has involved higher cost in the diagnosis
and management54. At the same time it does not cause any reduction in
the antibiotic use by the physicians. Hence we need a simple and cost
effective diagnostic tool which can be used in the emergency department,
well capable of diagnosing bacterial illnesses with acceptable sensitivity
and specificity.
CRP is sensitive enough in diagnosing bacterial illness but has low
specificity in ruling out the infections when the infection is not severe.
This again will not be a better guide in starting on antibiotics, giving the
benefit of doubt.
Procalcitonin when used in the emergency department can reliably
used in the diagnosis of bacterial illness in children. Based on that, the
primary physician can make an evidence based decision for initiating
antibiotics. Various meta analyses recommend the use of procalcitonin
based algorithms in the initial diagnosis and the management of sepsis.
MATERIALS AND METHODS
MATERIALS AND METHODS
Place of study
Department of Paediatrics, ESIC Medical College & PGIMSR,
K.K Nagar, Chennai
Study design:
Prospective descriptive study
Study period:
From February 2013 - October 2014
Study population:
All  children  (6  months  to  12  years  of  age)  admitted  to  the
Department of Paediatrics at ESIC Medical College & PGIMSR, K.K
Nagar, Chennai, with an acute febrile illness (temperature >100.4º F),
were enrolled in the study. An informed written consent was obtained
from their parents. A detailed history was recorded along with complete
clinical examination in a proforma. Provisional diagnosis was the one
made by the admitting physician. This was subsequently revised after
completion of the investigations
Inclusion criteria:
? Children  > 6 months with an acute febrile illness (< 14 days
duration) with a temperature of  >100.4º F
Exclusion criteria:
? Children who had received antibiotic treatment within 48 hours of
presentation to hospital
? Children with collagen vascular disorders
? Children with severe trauma
?  Children with burns
?  Children with major surgery
?  Children with prolonged shock
? Immunocompromised children
? Children vaccinated during the previous 48 hours
Investigations:
All children recruited were subjected to the following investigations:
? Complete blood count
? Peripheral smear
? Procalcitonin
? Hs CRP
? Blood culture
? Dengue serology
? Urine routine examination
? Urine culture
? Chest X ray
Lumbar  puncture  with  CSF  analysis  was  performed  as  and  when
the clinical situation mandated it.
Methodology:
2ml of blood was taken from the peripheral vein in a heparin
coated test tube for Hs-CRP and PCT estimation
Procalcitonin (PCT):
PCT was measured using BRAHMS – PCTQ semi quantitative
assessment kit. Labeled blood samples were collected and sent from the
ward to the laboratory. Both the hospital insurance number and the
inpatient number were written on each of the samples to avoid confusion.
Samples were then centrifuged at the rate of 3500 rpm for three minutes
and the serum was allowed to separate.
Execution:
The individual test package was not opened until immediately prior
to running the test. 6 drops of the serum (200 microlitres) was pipetted,
using the enclosed dropper pipette, and introduced into the round cavity
of BRAHMS PCT – Q kit and the rest of the sera were disposed. The kit
was incubated for 30 minutes at room temperature. After 30 minutes,
procalcitonin concentration range of the sample was determined. At first,
the validity of the test was ascertained with the clearly visible control
band  on  the  kit.  The  procalcitonin  concentration  range  was  then
determined by comparing the colour intensity of the test band with the
colour blocks on the reference card and documented as <0.5ng/ml or >0.5
ng/ml.
This  BRAHMS PCT –  Q kit  has  a  sensitivity  of  90  –  92% and  a
specificity of 92 – 98% compared to other methods of estimation. The
PCT  –  Q  is  marketed  as  a  point  –  of  –  care  testing  kit.  Results  are
indicated by four different shades of red, corresponding to different PCT
ranges, indicating the possibility and also the severity of sepsis.
Labeled BRAHMS PCT Q Kit with PCT estimation
Hs – CRP:
Labeled blood samples were sent from the pediatric ward. These
were subjected to centrifugation at 3500 rpm for 3 minutes and the sera
were allowed to separate. The serum was then added to the automated hs
CRP analyser. Various assay methods are available for CRP
determination, such as nephelometry and turbidimetry.
We used Roche/Hitachi Cobas C systems for the estimation of hs
CRP.  The  Roche  CRP  assay  is  based  on  the  principle  of  particle  –
enhanced immunological agglutination.
Test principle:
Particle enhanced immuno – turbidimetric assay
Human CRP agglutinates with latex particles coated with
monoclonal anti-CRP antibodies. The precipitate is determined
turbidimetrically.
Lower detection limit:
0.15 mg/L
Method of estimation of Hs CRP
Total and absolute neutrophil count estimation:
2ml of blood was taken in EDTA coated test tube, under aseptic
precautions, and sent to the laboratory with proper labeling. Total count
was analysed using Cobas C 5 part automatic cell count analyser. Results
which were displayed were noted down. The quality control for the
analyser was run once every day.
Machine used for the estimation of total count
From the total leucocyte count and the percentage of neutrophils in
the differential count, the absolute neutrophil count (ANC) was derived
using the formula given below:
                    Percentage of Neutrophils X Total Leucocyte count
ANC=   __________________________________________
                                             100
Blood culture:
1 ml of blood was taken under strict aseptic precautions in liquid
culture media (BHA broth) and incubated for 72 hrs in blood agar and
Mac conkey agar for the growth of any pathogenic organisms.
Urine culture:
5ml of urine is collected, by mid stream clean void, in a sterile test
urine container and incubated in Hi Chrome culture media. Results were
read after 24 hours for possible growth of organisms.
Results were documented for each patient and appropriate
treatment was initiated, as per the department’s standard protocol once
the final diagnosis was arrived at.
Statistical analysis
The results of procalcitonin, hs – CRP and absolute neutrophil
count were compared and analysed using pearson chi square method. The
diagnostic accuracy of all the parameters was then compared and
interpreted with reference to clinical data.
In the present study, the statistical methods were for quantitative
data, descriptive statistics was presented by N, Mean, Standard Deviation
and Range. For qualitative data, frequency count, N and percentage were
put in a tabular manner.
To analyze the data, an appropriate statistical test was applied so as
to find the association between parameters, Chi square test (2x2 cross
tabulation) was used. Screening tests such as Sensitivity, specificity, ROC
curve have been calculated.
All the statistical analysis has been done by using statistical
software SPSS (version 16.0). Other data, displayed by various tables and
charts, were done by using Microsoft excel (windows 7).
* Significant at p < 0.05
** Very significant at p <0.01
*** Highly significant at p < 0.001
The diagnostic accuracy of each parameter was also assessed by
calculating its area under receiver operating characteristics curve
(AUROCCs), which was plotted for the three main markers of infection
namely procalcitonin, hs CRP and ANC. AUROCC is a validated way to
measure the diagnostic accuracy of a test or the discriminatory power of a
prediction rule. AUROCC values can have a range from 0.5 to 1.0
wherein a value of 0.5 would indicate a test that is of little use while a
value of 1.0 would indicate a perfectly discriminatory test. In practice, a
test with an AUROCC value of less than 0.75 would not be considered as
contributory.
OBSERVATIONS AND RESULTS
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TABLE-1
GROUP CHARACTERISTICS
Character No. of cases [n (%)]
0-5 years 103 (60.1%)
6-12 years 155 (39.9%)
Male 158 (59.7%)
Female 108 (40.3%)
Fever <7 days at presentation 241(93.3%)
Fever >7 days at presentation 17 (6.6%)
No. of cases with procalcitonin 258 (100%)
No.of cases with CRP 258 (100%)
No.of cases with ANC 258 (100%)
No.of cases with blood culture 152 (58.9%)
No.of cases with  urine culture 122 (47.2%)
INDIVIDUAL PARAMETERS
Table 2
Age distribution of the study population
Study population 0 – 5 years 6 – 12 years
258 103 155
Total no. of cases – 258
Children in age group 0 to 5years – 103
Children in age group 6 to 12 years – 155
155
103
Fig. 5: Age distribution
< 5 YEARS
> 5 YEARS
Table – 3
Association between levels of serum procalcitonin and age group
Procalcitonin(ng/ml)
Pearson
Chi-
Square
value, df
P value
Age
(years) < = 0.5 > 0.5 Total
0.889
(a),1 0.346
0—5 118(61.8%)
37
(55.2%)
155
(60.1%)
5—12
73
(38.2%)
30
(44.8%)
103
(39.9%)
Total 191(100%)
67
(100%)
258
(100%)
An attempt was made to compare the levels of procalcitonin in
children less than 5 years and older children to look for any significant
differences, as it is a well known fact that elevated PCT levels may be an
indicator of severe bacterial infections in younger children. In both the
age groups, 0 – 5 yrs and 5 – 12 years it is not statistically significant.
Table –4
Sex distribution of the study population
Study population Male Female
258 150 108
Total number of cases – 258
No. of male children – 150
No. of female children – 108
Male:female–1.4:1
150
108
Fig. 6:   Sex distribution
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Table – 5
Association  between serum procalcitonin and gender:
Procalcitonin(ng/ml)
Pearson
Chi-Square
value, df
P
value
Gender < = 0.5 > 0.5 Total
0.085 (a),1 0.771
Female 78(40.8%)
26
(38.8%)
104
(40.3%)
Male 113(59.2%)
41
(61.2%)
154
(59.7)
Total 191(100%)
67
(100%)
258
(100%)
There appear to be no significant differences in the procalcitonin
levels among boys and girls. The pearson chi square value is not
statistically significant.
Table – 6
Proportion of bacterial and viral infections in the study population
Study population Bacterial infections Viral infections
258 56 202
Total no. of cases – 258
No. of cases diagnosed with bacterial infection* - 56
No. of cases diagnosed with viral infection – 202
Viral infection: bacterial infection – 3:1
*Bacterial infection proven by the growth of pathogen in blood/
urine/ other body fluids and diseases known to have been caused by
bacteria most commonly, though confirmatory evidence is not obtained,
like pneumonia
56
202
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Fig. 7- Proportion of infection
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Table – 7
Bacterial infections in the study population
Study
population
Enteric fever UTI Others
56 35 10 11
Of  the total 56 cases with bacterial infections, 62.5% had enteric
fever, 17.1% had UTI and remaining 19.6% had other bacterial
infections.
Fig. 8
Bacterial infections in the study population
Total no. of cases diagnosed with bacterial infections – 56
Enteric fever – 35
Urinary tract infection – 10
Pneumonia – 5
Tonsillitis – 4
Acute suppurative otitis media (ASOM) – 2
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Table – 8
Clinical characteristics Association  between total duration
of fever and  serum procalcitonin levels
Procalcitonin(ng/ml)
Pearson
Chi-
Square
value, df
P value
Fever
(days)
< = 0.5 > 0.5 Total
0.056
(a),1
0.812
Up to 7
178
(93.2%)
63 (94%)
241
(93.4%)
Above 7 13 (6.8%) 4 (6%) 17 (6.6%)
Total
191
(100%)
67(100%) 258(100%)
In the two groups i.e. fever <7 days and > 7 days, the degree of rise
of procalcitonin does not correlate with the duration of fever. The pearson
chi square test for this is not statistically significant, P >0.5.
Table – 9
Association  between day of defervescence of fever and serum
procalcitonin values
Procalcitonin(ng/ml)
Pearson
Chi-
Square
value, df
P
value
Fever
defervescence
(days)
< = 0.5 > 0.5 Total
4.75 (a),1 0.029*
<=5
179
(93.7%)
57
(85.1%)
236
(91.5%)
>5
12
(6.3%)
10
(14.9%)
22
(8.5%)
Total
191
(100%)
67(100%)
258(100
%)
Among 22 children who defervesced after 5 days of admission,
14.9% cases had procalcitonin levels more than 0.5ng/ml. This
association is statistically significant with P < 0.05 (P = 0.029)
Table-10
Association  between serum procalcitonin and final diagnosis
Procalcitonin values obtained were grouped into two, namely, <
0.5 ng/ml and >0.5ng/ml. Of the total 56 cases with bacterial infections,
35 cases had serum procalcitonin values >0.5ng/ml (62.5%). Thirty two
cases with viral illness had (15.5%) procalcitonin values >0.5%.
Final diagnosis
Pearson
chi-
square
value, df
P value
Procalcitonin
(ng/ml)
Bacterial
infections
Viral
infections
Total
49.649(b),
1
<0.0001***
< 0.5
21
(37.5%)
170(84.2%)
191
(74%)
> 0.5
35
(62.5%)
32 (15.8%)
67
(26%)
Total
56
(100%)
202 (100%)
258
(100%)
Remaining 170 cases (84.2%) had procalcitonin values <0.5ng/ml.
This indicates a strong association between high serum procalcitonin
values and bacterial infections (p<0.0001).
Table – 11
Association  between blood C/S and serum procalcitonin
Procalcitonin(ng/ml)
Pearson
chi-
square
value, df
P value
Blood c/s < = 0.5 > 0.5 Total
  22.864(b)
1
<0.0001
***
Positive
12
(6.3%)
19
(28.4%)
31
 (12%)
Negative
179
(93.7%)
48
(71.6%)
227
88%)
Total 191(100%)
67
(100%)
258
(100%)
Of the total 56 cases with bacterial infection, 35 cases had enteric
fever. 31 cases were culture positive; 19 cases with PCT >0.5ng/ml  had
blood culture positivity (28.9%) and 48 cases with culture negativity also
had PCT >0.5ng/ml (71.6%).  The P value for this observation is
<0.0001* which is highly significant i.e. there is a strong association
between culture positive cases and PCT >0.5ng/ml.  Of the total 191
cases with PCT <0.5ng/ml, 171 cases had culture negativity and 12 cases
had culture positivity who turned out to be enteric fever.
Table – 12
Association  between urine c/s and serum procalcitonin
Procalcitonin(ng/ml)
Chi square
(continuity
correction(b))
value, df
P value
Urine c/s < = 0.5 > 0.5 Total
15.962,1 <0.0001***
Positive 1(0.5%) 8(11.9%) 9 (3.5%)
Negative
190
(99.5%)
59
(88.1%)
249
(96.5%)
Total
191
(100%)
67
(100%)
258
(100%)
A total of 8 urine culture positive cases (11.9%) had PCT values
>0.5ng/ml and only one case has the PCT <0.5. Of the total of 249 cases
with negative urine culture, 190 cases (99.5%) had PCT <0.5ng/ml and
only 59 cases had PCT (88.9%). As per the pearson chi square test, the P
value is <0.0001 *** and this association is highly significant statistically.
Table –13
Evaluation of serum procalcitonin as a diagnostic test
For the above observation as per Pearson chi square test,
procalcitonin is highly significant in detecting bacterial infection, p
<0.0001.
The sensitivity and specificity of this test 62.5% and 84.16%
according to Wilson’s test within 95% confidence interval. The positive
predictive value, which rules in an infection, is 52.24% but the negative
predictive value, which rules out an infection, is 89%.
Parameter Estimate
Lower - Upper
95%
confidence
intervals Method
Sensitivity 62.50% (49.41, 73.99 ) Wilson score
Specificity 84.16% (78.49, 88.55 ) Wilson score
Positive predictive
value 52.24% (40.48, 63.75 ) Wilson score
Negative predictive
value 89.01% (83.78, 92.7 ) Wilson score
Diagnostic accuracy 79.46% (74.11, 83.94 ) Wilson score
Fig. 9
Serum procalcitonin and final diagnosis
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Table –14
Association  between hs CRP and final diagnosis
Of the 56 cases with bacterial infection, only 48 cases had CRP
values of more than 10mg/l (85.7%) and the remaining 8 cases had CRP
values of less than 10mg/l (14.3%). Of the total of 202 cases with viral
infection, 125 cases had raised CRP values (61.9%) and the rest had CRP
values less than 10mg/l. Thus CRP is very sensitive in detecting  bacterial
infections, with p value  <0.001 which is highly significant.
Final diagnosis
Pearson
chi-
square
value, df
P value
hs
CRPmg/L
Bacterial
illness
Viral
 Illness
Total
11.273(b),
1
<0.001**
< =10 8 (14.3%) 77 (38.1%) 85(32.9%)
> 10 48(85.7%) 125(61.9%) 173(67.1%)
Total 56 (100%) 202 (100%) 258(100%)
Table – 15
Evaluation of hs CRP as a diagnostic test
Parameter Estimate
Lower - Upper
95% CIs Method
Sensitivity 85.71% (74.26, 92.58 ) Wilson score
Specificity 38.12% (31.7, 44.98) Wilson score
Positive predictive
value(PPV) 27.75% (21.61, 34.85 ) Wilson score
Negative predictive
value (NPV) 90.59% (82.51, 95.15 ) Wilson score
Diagnostic accuracy 48.45% (42.42, 54.53 ) Wilson score
As per pearson-chi square test, the sensitivity of CRP in detecting
bacterial infection is 85.71% and the cut off limit is 10mg/l and
specificity is 38.12%
Positive predictive value is 27.75% and the negative predictive
value is 90.59 % as per Wilson’s method of analysis. The diagnostic
accuracy of CRP in detecting bacterial infection is 48.45%.
Fig. 10
hs CRP and final diagnosis
177 children with CRP with <10mg/l had viral infection and 125
children with CRP >10 mg/l had viral infection.
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Table 16
Association  between absolute neutrophil count (ANC) and final
diagnosis
ANC
cells/mm3
Final Diagnosis
Pearson
Chi-
Square
value, df
P value
Bacterial
infection
Viral
infection Total
6.504(b),
1
<0.011*< =5000 27(48.2%)
135
(66.8%) 162(62.8%)
> 5000 29(51.8%) 67(33.2%) 96 (37.2%)
Total 56 (100%) 202(100%) 258 (100%)
Absolute neutrophil count is not a very sensitive or specific marker
of bacterial infection in children because of age dependent variation in
the leucocyte count in children. In our study, of the total of 258 children,
135 children (66.8%) who had viral infections had ANC of <5000
cells/mm3.
Table 17
Association between absolute neurophil count (ANC) and
Procalcitonin
     ANC
Cells/mm3
Procalcitonin ng/ml
<=0.5 >0.5 Total
<=5000 132(69.1%) 30(44.8%) 162(62.8%)
>5000 59 (30.9%) 37 (55.2%) 96(37.2%)
Total             191
(100.0%)
67
(100.0%)
258
(100.0%)
55.2% of the children with PCT >0.5ng/ml have ANC value of
>5000 cells/mm3 and 69.1% children with ANC <5000cells/mm 3 have
PCT value of <0.5ng/ml
Table – 18
Evaluation of ANC as a diagnostic test
Parameter Estimate
Lower - Upper
95% CIs
Method
Sensitivity 51.79% (39.01, 64.33) Wilson Score
Specificity 30.93% (22.6, 40.7) Wilson Score
Positive Predictive Value 30.21% (21.93, 40.01) Wilson Score
Negative Predictive Value 52.63% (39.92, 65.01) Wilson Score
Diagnostic Accuracy 38.56% (31.22, 46.47) Wilson Score
As per pearson-chi square test, the sensitivity of ANC in detecting
bacterial infection is 51.79% and the specificity is 30.93%.
Positive predictive value is 30.21% only and the negative
predictive value is 52.63% as per Wilson’s method of analysis. The
diagnostic accuracy of ANC in detecting bacterial infection is only
38.56%.
Table 19
Student t test and the group statistics between the variables, ANC &
bacterial illness
Final
Diagnosis N Mean Std. Deviation
Std. Error
Mean
      ANC
Bacterial
infection
56 6135.3589 3549.38911 474.30707
Viral infection 202 5017.3125 4096.87890 288.25539
As per the t – test, the mean value of ANC in cases with bacterial
infection is  >6000 cells/mm3 and for viral illness ANC <6000 cells/mm3
Table-20
Student t test and the group statistics between the variables ANC &
PCT
Procalcit
o-nin
ng/ml N Mean
Std.
Deviation
Std. Error
Mean
ANC < 0.5 191 4853.6749 3895.01973 281.83374
> 0.5 67 6418.2884 4114.69417 502.68990
As per the t–test, in the study population who had bacterial
infection, the mean value of ANC is 6418 and in the same group with
PCT <0.5ng/ml, the mean value of ANC is 4853.
Fig. 11
Absolute neutrophil count and final diagnosis
 Proportion of bacterial infection with ANC <5000 cells/mm3 is 48.2%
and those with ANC>5000 cells/mm3 is 33.2%
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Absolute neutrophil count and procalcitonin
Significant proportion of children with ANC <5000 had bacterial
infections and only few children with ANC>5000 had viral infections
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Receiver operating characteristic (ROC) curve for
PCT, hs CRP & ANC
ROC curve for  procalcitonin ,  ANC and  HS CRP with respect  to
sensitivity and specificity.
Table – 21
Determination of area under curve (AUC) with ROC
Area Under the Curve (AUC)
Test Result Variable(s) Area
ANC 0.628
HS CRP 0.717
PCT 0.755
Procalcitonin has the greater AUC (0.755) as compared to hs CRP
(0.717) and  ANC (0.628)
Table 22
Comparison of characteristics of PCT, Hs CRP and ANC
Parameter PCT Hs CRP ANC
Sensitivity
62.50%
85.71% 51.79%
Specificity 84.16% 38.12% 30.93%
PPV
52.24% 27.75% 30.21%
NPV 89.01% 90.59% 52.63%
Diagnosticaccuracy 79.46% 48.45% 38.56%
Odds ratio 8.854 3.696 0.4809
DISCUSSION
DISCUSSION
Children presenting to the outpatient department or being admitted
as inpatients for fever is a very common problem in practice. Majority of
these infections are viral in etiology and are easy to identify but a lesser
proportion are bacterial requiring antibiotic therapy and more
importantly, having the potential to evolve into serious infections like
sepsis, meningitis etc. which can give rise to considerable morbidity and
mortality.
This is particularly true for children less than 3 years of age in
whom signs and symptoms may be subtle and can be missed by even the
most experienced pediatrician. The need for coming to a diagnosis
rapidly, coupled with the need for judicious use of antibiotics is a major
challenge. A rapid diagnosis and treatment is important to reduce the
progression to severe bacterial infections (SBI) which will result in
poorer outcomes.
Also, the quicker the diagnosis is made the use of antibiotics can be
justifiably reduced thereby reducing resistance and unnecessary costs of
hospitalization can be avoided. So, the major aim in evaluating febrile
children  is  –  is  this  infection  bacterial  or  not  and  can  it  progress  to  an
SBI?
Much research has gone into finding the ideal marker that will
pinpoint bacterial infections from amidst many viral infections. The ideal
marker would be one with very high sensitivity and specificity, one which
should rise very rapidly after the onset of the infection and most of all,
should be easily available and not too expensive.
From  amongst  the  various  bio  markers  PCT,  hs  CRP  and  ANC
have been studied rather frequently with varying reports on their
reliability in predicting bacterial infections. This study was designed to
compare these three parameters among febrile children, presenting to the
OP/ IP, as to their accuracy in predicting bacterial infections.
The study population comprised of children who satisfied the
inclusion criteria. Immediately after admission and diagnosis, blood
samples were drawn for appropriate investigations, and based on the
investigations, a final diagnosis was made and categorized into bacterial
or viral infection. Treatment was initiated as per standard departmental
protocol.  PCT,  hs  CRP,  ANC  values  were  compared  with  the  final
diagnosis with regard to accuracy in diagnosing bacterial infections.
Procalcitonin:
Age related differences in the rise of procalcitonin value were
studied  (Table2).Very young children do not show any localising signs
even in serious infectious conditions and in these situations biomarkers
are used to aid the diagnosis. Procalcitonin values are not related to
difference in age.
On comparing  the  efficacy  of  procalcitonin  with  the  different  age
groups, it was found that procalcitonin is not an effective tool in the
differentiation of  bacterial illness from viral illness in  children based on
the age alone. Children in both the age groups showed a similar increase
in procalcitonin while having a bacterial illness.
One clinical observation which deserves special mention is that
children who are very young and present with shock during an acute
febrile illness, have a significant increase in procalcitonin values above 2
ng/ml.
Quantitative measurement of procalcitonin can be of much use in
estimating the severity of infection in such a sick child. In a meta analysis
by Yo et  al,  eight  studies were analysed which contained  children < 36
months. They got a mean sensitivity of 83% and specificity of 89% for
procalcitonin. This is in accordance with our study, the overall sensitivity
being 62.5% and the specificity 84.1%.
Sex distribution:
The male: female ratio was approximately 1.4:1 (Fig. 7) There are
no sex related variations in the distribution of procalcitonin values
described in literature. Our study also did not show any relationship of
PCT with reference to gender (Table 3).
Majority of the children admitted to our hospital had viral
infections, 202 cases of the total 258 cases. The remaining 56 children
had bacterial infection namely enteric fever, urinary tract infection (both
of which had definite bacterial isolates on culture) and pneumonia and
ASOM, which are mostly due to bacterial infection in children. The ratio
of bacterial to viral illnesses was approximately 1:3 in our study
population. Among the bacterial infections in our study, we had a higher
proportion of enteric fever (35 cases), followed by urinary tract infection
(10 cases).
Coming to the main study characteristic, serum procalcitonin level
was >0.5ng/ml in 62.5% of children with bacterial infections, whereas
only 15.8% of children who were diagnosed to have a viral infection had
a PCT >0.5ng/ml. 84.2% of the children who had a PCT<0.5ng/ml were
diagnosed to have a viral illness. Thus it can be inferred that the true
positive values of PCT are more in case of bacterial infections. Hence,
PCT has good predictive value for bacterial infection. As per the pearson
chi square test, this is statistically significant with P <0.0001*(Table –
11). This result is similar to the results obtained by Simon et al and the
meta  analysis  by  Yo  et  al,  which  showed  a  similar  significance  of
P<0.05.
The sensitivity of procalcitonin in detecting bacterial infections at a
cut off of >0.5ng/ml comes to 62.5% and the specificity is 84.1%.  These
results are correlating with the results obtained by Andreola et al56. In
their prospective, observational study done in 2007, in a pediatric unit,
they enrolled 408 cases and evaluated the role of PCT, hs CRP and ANC
in diagnosing bacterial infections in the age group <36 months. The
sensitivity obtained in their study was 87.5% and specificity was 50%.
In our study, with the above sensitivity and specificity the positive
predictive value of PCT is 52.4% and the negative predictive value is
89.01%. The diagnostic odds ratio for PCT is 8.854 (4.577 – 17.13).The
positive likelihood ratio of PCT in predicting bacterial illness is 3.945 -
(3.588 – 4.338) and negative likelihood ratio is 0.4456 (0.405 – 0.4902).
This is similar to the results of Andreola et al and other studies.
 Lacour et al57, in their study in 2008, achieved a positive
likelihood ratio of 4.92 (95% CI 3.26 – 7.43) and a negative likelihood
ratio of 0.07 (0.02 – 0.27). They used a triad of urine dipstick testing
along with hs CRP and PCT. The study by Thayyil et al58 in 2005,
reported the highest positive likelihood ratio of 10.67 (95% CI 2.9 –
39.3).
They had used thresholds for all the three blood tests i.e.
procalcitonin > 2 ng/ml, hs CRP > 50 mg/l, and a WBC count of  >15 X
109/l. The major drawback of this study was the negative likelihood ratio
of 0.52 (0.25 – 1.05) which lacked ‘rule out’ value. That is this triad of
cut off values could accurately ‘rule in’ but not ‘rule out’ bacterial
infections.
Two studies have looked at the predictive value of hs CRP and
PCT in febrile children less than 16 years of age, similar to our study. The
largest one was by Gendrel et al, wherein PCT values were ascertained
for 700 children and in about 360 patients an infectious etiology was
obtained.
Children were assigned to three groups based on the final diagnosis
– invasive bacterial infections (n=46), localized bacterial infections
(n=78)  and  viral  infections  (n=236).  The  mean  PCT  level  of  the  first
group was 45.9 ng/ ml, the second was 4.2 ng/ ml and the third was 0.4
ng/ ml. PCT was found to be the most useful test, the next best being hs
CRP.
Our study has remarkable similarities with the one done by
Gendrel in that we too recruited all children less than 12 years of age, our
proportions of children with bacterial and viral infections were about the
same, PCT performed much better than hs CRP as a diagnostic tool to
rule out bacterial infections and lastly, all patients were hospitalized.
Putto et al59 studied hs CRP and WBC counts in 151 children and
reported that hs CRP had a far superior sensitivity (100%) and specificity
(75%) for the detection of bacterial infection and that WBC counts were
far less sensitive and specific.
Thus, PCT has a diagnostic accuracy of 79.46%, in our study, in
predicting bacterial infections in febrile children. Hence PCT is the best
marker in reasonably excluding bacterial infection if the values are <0.5.
Also, procalcitonin has a higher negative predictive value (89%) than
positive predictive value (52.2%), in our study, hence it can be used for
excluding or ‘rule out’ serious bacterial infections in children.
Further,  on  comparing  the  characteristics  of  culture  proven
bacterial infection with procalcitonin values, the following could be
inferred. Of the total of 31 cases with blood culture positive, 19 cases
(61.3%) had PCT values >0.5ng/dl. On the other hand, 227 cases with
sterile blood culture, 179 cases (93.7%) had PCT values <0.5ng/ml. Thus,
this supported our observation that PCT can be safely used in the
exclusion of septicemia. The association is statistically significant with
p<0.05 as per pearson chi square test.
Among the loco-regional infections studied, namely, urinary tract
infections (UTI) in our case, it was found that PCT had a significant
predictive value in diagnosing UTI. Literature search shows that the rise
of PCT can be used in predicting upper urinary tract involvement.
In a study by Leroy et al60 in 2011, PCT was found to demonstrate
a reasonable diagnostic accuracy for both acute pyelonephritis and renal
scarring and was a more accurate predictor than either  hs CRP or WBC
count. 99.5% cases with negative urine culture had PCT values <0.5ng/ml
and only one case with positive urine culture had PCT <0.5 where as
88.9% cases with urine culture positivity had PCT values >0.5.
The rise of PCT correlates well with urinary tract infection with or
without upper urinary tract involvement. Our study contained only cases
with lower urinary tract involvement. Hence, it can be concluded that,
UTI can be almost excluded if PCT <0.5ng/ml. The Pearson chi square
correlation test for PCT in diagnosing UTI is highly significant with
P<0.0001*.
Yidiz  et  al  studied  hs  CRP  as  a  marker  of  renal  scarring.  They
found that the rise of CRP can be correlated with renal scarring. Xu et al
investigated the role of PCT in diagnosing UTI and found that PCT has a
role in predicting pyelonephritis better than with hs CRP.
They noted that the average PCT and CRP levels were much higher
in children with acute pyelonephritis than in those with lower UTIs
(p<0.01) while white cell counts were not useful in predicting renal
involvement. The areas under the PCT, CRP and, WBC curves were
0.958, 0.858 and 0.588 respectively.
Since there is no existing literature regarding varying combinations
of clinical data and the procalcitonin values, an attempt was made in our
study for the same. We attempted to study the association between total
duration of fever in days and the rise of serum procalcitonin levels.
Statistical analysis showed that the association between the two
was not significant but suggestive. That is children who present to us with
more than 7 days of fever have a high likelihood of evolving into a
bacterial infection. This is also supported by the fact that most self
limiting viral illness in pediatric age group lasts for not more than a week.
The statistical association between the total number of days of fever at
presentation to the rise of  procalcitonin was weak in our study with a P
>0.05.
Further, procalcitonin values were analysed with the day of clinical
defervescence of fever to see whether initial levels of PCT correlated
with defervescence of fever. Of the total of 258 cases, 236 cases had
fever defervescence in less than 5 days (91.5%). Of the total, 8.5%
children had fever defervescence after 5 days, 12 cases had serum
procalcitonin values <0.5ng/ml and 10 cases had >0.5ng/ml.
This association was statistically significant with P <0.05. The
inference being, higher the rise of procalcitonin, higher the possibility of
bacterial infection and more is the time taken for fever defervescence. At
the time of writing, a study conducted by the National Institutes of
Health, looking at this association has been completed. The results of this
study are yet to be made public.
Hs CRP:
The second parameter  studied was hs CRP. Hs CRP had a cut  off
level of 10 ng/ ml in our study for the presumptive diagnosis of bacterial
infection. This low value was taken as cut off because the kit used in our
study has a very high sensitivity of detecting values as low as 0.2 ng/ml.
With this cut off, of the total 173 children with values more than 10, 48
had bacterial illness and 125 cases had viral illness.
This can be interpreted as 85.7% of the children with bacterial
illness and 61.9% of the children had viral illness had CRP value of
>10mg/L. Only 14.3% (8 cases) had hs CRP values of < 10mg/L, were
diagnosed to have a bacterial infection. This has statistical significance of
P<0.001 with pearson chi square test.
The sensitivity of hs CRP in detecting bacterial infection is 85.71%
and specificity is 38.12%. The low specificity of CRP in our study can be
because of  the lesser  cut  off  of  CRP used for  the diagnosis  and the fact
that CRP was evaluated early in the course of the disease well before the
CRP values actually started to peak.
In a meta analysis by Yo et al, in studying the test characteristics of
procalcitonin and CRP in detecting possible serious bacterial infection,
they reviewed a study done by Olaciregui et al61, in 2009. It was a
prospective observational study. They used a higher cut off level of CRP
of 30 ng/ ml with a prevalence of serious bacterial infection of 23.63%.
They obtained a sensitivity of 63.4% and a specificity of 84.2%.Yo et al
found the mean AOC for CRP to be 0.84, which is correlating with our
study in which the AOC for CRP is 0.717.
The positive predictive value of CRP in our study is 27.75% which
is less than that for procalcitonin. The negative predictive value of CRP is
high 90.59% and is comparable to that of procalcitonin i.e. 89%.
Thus, it can be concluded that CRP is inferior to procalcitonin in
diagnosing or ‘ruling in’ bacterial infection. The positive likelihood ratio
of CRP is 1.385 (1.354 – 1.417) and the negative likelihood ratio is 0.374
(0.2815 – 0.499) which are inferior to those obtained with procalcitonin.
The diagnostic odds ratio comes around 3.696 for CRP.
ANC:
Moving on to the third marker in our study, namely, absolute
neutrophil count, statistical analysis shows that it does not correlate well
with bacterial infections. Based on group statistics, the mean value of
ANC in the cases with bacterial illness is 6135 cells a standard deviation
of 3549 cells and a standard error of 474 cells..
Similarly in the study group with PCT >0.5ng/ml, the mean ANC
is 6418 cells. Thus bacterial infection can be suspected if ANC is
approximately >6000cells/mm3.  It is also seen that the mean ANC if the
PCT values are <0.5ng/ml is 4853 cells. Of the total 96 children with
ANC >5000, only 29 had bacterial illness and the remaining 67 had viral
illnesses. Thus to conclude, bacterial infection can be predicted if PCT
>0.5ng/ml and ANC is more than 6000 cells/mm3.
         ANC alone is not a reliable indicator in diagnosing bacterial
infection. In our study, the sensitivity of ANC in detecting bacterial
infection is 51.79% and the specificity is 30.93%. Thus, ANC is inferior
to both PCT and hs CRP in detecting bacterial infection in febrile
children.
The positive predictive value of ANC is 30.21% and the negative
predictive value is 52.63% with a diagnostic accuracy of 38.56%. This is
in accordance with the study conducted by Thayyil et al[58] in 2005 using
leucocyte count. They found a sensitivity of 50 % and a specificity of
53.1% in diagnosing bacterial infection. In our study, the positive
likelihood ratio of ANC in detecting bacterial infection is 0.7497(0.6837 -
0.8221) and a negative likelihood ratio is 1.559(1.253 - 1.94) which is
third  after  PCT  and  hs  CRP.  The  diagnostic  accuracy  of  ANC  is  thus
38.56% which is much less than that for PCT and CRP.
This was further supported by the area under the curve being the
least for ANC (0.628) which makes it a poor test. These findings are
similar to those reported by Andreola et al.
          The accuracy of the diagnostic test is to be evaluated with the
positive predictive value of that test and the area under curve given by the
receiver operating characteristic curve. The positive predictive value of
procalcitonin is higher compared to hs CRP and absolute neutrophil count
in predicting bacterial infection. Thus procalcitonin when used in
isolation can be relied upon to diagnose bacterial infection. This is in
accordance with several studies available in literature.
CRP at a cut off of 10 mg/l is inferior to procalcitonin in detecting
bacterial infection in our study though it is statistically significant. The
results of hs CRP have to be interpreted in accordance with the clinical
condition of the patient. ANC cannot be reliably used in the diagnosis of
bacterial infection in isolation.
         Likewise, among all the three parameters, PCT has the highest AUC
(0.755) followed by CRP (AUC 0.717) and ANC (AUC 0.628). This is in
accordance  with  the  review  study  conducted  by  Yo  et  al  in  which  PCT
had the highest AUC compared to CRP and total leucocyte count.
To conclude, among ANC, hs CRP and procalcitonin, procalcitonin
emerges as the single best diagnostic marker in identifying bacterial
infection in febrile children. Procalcitonin is a more specific rather than a
sensitive marker in diagnosing bacterial illness. Thus PCT can be used to
exclude possible serious bacterial infection when the values are <0.5ng/dl
and when used as a single parameter.
                In the emergency department, either PCT can be used either
singly or in combination with hs CRP in diagnosing bacterial infection.
Having said that, it has to be kept in mind that, since the costs associated
with missing serious bacterial infection is high, we recommend that
procalcitonin should not be used in isolation. It is always better to use it
along with other biomarkers. Many clinical trials have shown better
advantages in term of patient improvement and cost reduction i.e.
showing a high cost benefit ratio when procalcitonin was used in the
management algorithm.
                     From our study, based on the above statistical analysis, we
could suggest the following parameters pointing towards bacterial
infection:
1) Fever >7 days
2) Procalcitonin >0.5ng/ml
3) Hs crp >10mg/L
4) Absolute neutrophil count >6000cells/cumm
5) Total days of fever defervescence >5 days
Thus in future, a clinical score can be evolved with much larger
studies predicting the possibility of bacterial infection
In summary, our study showed that PCT performs better than hs
CRP in detecting bacterial infection. Considering the fact that the
sensitivity is rather poor and specificity is acceptable, values <0.5ng/ml
can reasonably used for ruling excluding bacterial infection. However,
PCT values >0.5ng/ml are not confirmatory evidence of a bacterial
infection.
At this point, the available literature does not show how to
combine procalcitonin with clinical data to improve the overall diagnostic
performance. Larger studies are essential in children with accurate study
design for the same .
CONCLUSION
CONCLUSION
? Procalcitonin may be useful, as a single test, in identifying bacterial
infections in febrile children.
? Bacterial infections may be reasonably excluded if  PCT values are
<0.5ng/ml
?  Hs - CRP is comparable with PCT in identifying bacterial
infection
?   ANC is less useful in identifying bacterial infection.
LIMITATIONS
LIMITATIONS
? The kit used for measuring serum procalcitonin is a semi
quantitative method. Hence absolute values of PCT were not
estimated.
? Multiple i.e. serial estimations of the inflammatory markers were
not done. Serial procalcitonin measures will not only indicate
improvement, but will also limit the duration of unnecessary
antibiotic therapy.
? More  than  60%  of  the  children  enrolled  in  this  study  were
diagnosed to have viral infection. Hence procalcitonin values were
better for ruling out bacterial infection.
? The  cut  off  values  for  CRP  is  taken  as  10  mg/L  which  were  less
compared to literature previously studied.
RECOMMENDATIONS
RECOMMENDATIONS
? In children presenting with fever, at all age groups, procalcitonin
along with hs-CRP may be used as a rapid screening test to
ascertain the likelihood of bacterial infections.
? A well designed study correlating clinical and vital signs along
with testing for hs-CRP and PCT needs to be carried out from
which a risk prediction score can be evolved.
? Further studies to ascertain different cut off values for PCT are
needed – one which will  decide the start  of  antibiotic  therapy and
another that will determine the discontinuation of treatment.
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PROFORMA
SAMPLE NO
? Name                       DOA-                                           IP no-
? Age                          DOD-
? Sex
? Informant                                                       Provisional diagnosis-
? Reliability
? Address
? Presenting complaints with duration:
?  h/o Fever -
? h/o Cough & cold-
? h/o  Vomiting-
? h/o  Loose stools-
? h/o  Abdominal pain –
? h/o  Myalgia-
? h/o  Burning micturition –
? h/o  Seizures-
? h/o  Yellowish discoluration of eyes, urine-
? Past h/o:
? Family h/0 – connective tissue disorders:
? Drug h/o-
Examination
? Vital signs-
? General examination-
? Systemic examination-
           CVS-
           RS-
          ABDOMEN-
CNS
Investigations :
? Total count & Differential count
? Peripheral smear study
? Hs CRP
? Serum Procalcitonin level
? Defervesence of fever
? LFT
? Blood culture
? Urine culture
? CXR
? Final diagnosis
? Treatment
PATIENT CONSENT FORM
Study title:
SERUM PROCALCITONIN AS A DIAGNOSTIC MARKER OF BACTERIAL
INFECTION IN FEBRILE CHILDREN
Study centre:  ESI-PGIMSR, K.K.Nagar, Chennai
Participant name:                                                Age:                         Sex:
I.P.No:
            I confirm that I have understood the purpose of procedure for the above study.
I  have  the  opportunity  to  clarify  all  my  queries  and  doubts  and  they  have  been
answered to my satisfaction.
            Investigator explained very well about the procedure and I am made aware of
the safety, advantage and disadvantage of the technique.
            I understand that my participation in the study is purely voluntary and that I
am free to withdraw at anytime without giving any reason.
            I have understood that the investigator, regulatory authorities and the ethics
committee will have access to my health records both in respect to current study and
any further research that may be conducted in relation to it, even if I decide to
withdraw from the study. I have understood that my identity will not be revealed in
anyway and information released to third parties or published, unless as required
under the law. I agree not to restrict the use of any data or results that arise from the
study.
          Without  any  compulsion  I  am  willing  to  give  consent  for  the  participation  of
my child in this study.
Date:                                                                               Signature / thumb impression
of patient
Place:
                                                                                          Patient name:
Signature of the investigator:
Name of the investigator:
Sl.No Age in years Age sex Fever  TLC Neutrophils ANC
HS
CRP Procalcitonin
blood
C/S Urine c/s Defervescence
final
diagnosis
1 sabari 4 Male 4 5900 36 2124 10 < 0.5 Positive Negative 2
Bacterial
illness
2 harish 2 Male 5 24000 57 13680 10 < 0.5 Negative Negative 6 Viral illness
3 dharsini 6 Female 5 4000 49.4 1976 2 < 0.5 Negative Negative 2 Viral illness
4 mathiyarasan 1 Male 4 10000 42.1 4210 10 < 0.5 Negative Negative 2 Viral illness
5 madhesh 2 Male 4 6100 58.7 3580.7 49.5 < 0.5 Positive Negative 3
Bacterial
illness
6 tharun 3 Male 10 8500 27.2 2312 12.2 < 0.5 Negative Negative 3 Viral illness
7 prakash kumar 12 Male 3 10200 56.4 5752.8 147.1 < 0.5 Negative Negative 3 Viral illness
8 raghav 2 Male 4 13400 67.3 9018.2 17.2 < 0.5 Negative Negative 3
Bacterial
illness
9 harikrishnan 7 Male 3 9400 71.2 6692.8 10 < 0.5 Positive Negative 4
Bacterial
illness
10 srimathi 6 Female 9 18800 84.1 15810.8 89 < 0.5 Negative Negative 2 Viral illness
11 naveena 12 Female 2 9300 80 7440 4.8 < 0.5 Negative Negative 2 Viral illness
12 naveen kumar 10 Male 2 9100 74 6734 5.1 < 0.5 Negative Negative 3 Viral illness
13 mounica 10 Female 5 6700 47.4 3175.8 55.8 < 0.5 Positive Negative 7
Bacterial
illness
14 sethupriya7 10 Female 9 5700 72.7 4143.9 119.2 0.5-2.0 Positive Negative 5
Bacterial
illness
15 priya 10 Female 4 9700 32.6 3162.2 2.7 < 0.5 Negative Negative 2 Viral illness
16 manimegalai 3 Female 4 19500 70.9 13825.5 18.6 < 0.5 Negative Negative 3 Viral illness
17 boni 9 Male 7 6500 64.7 4205.5 48.5 0.5-2.0 Positive Negative 6
Bacterial
illness
18 vaishnavi 10 Male 3 5300 49.4 2618.2 10 < 0.5 Negative Negative 6 Viral illness
19
julian immanuael
rohith 6 Female 7 18700 88.5 16549.5 1.1 < 0.5 Negative Negative 1 Viral illness
20 nithish raj 1 Male 1 30000 58.1 17430 10.9 2.1-10 Negative Negative 1 Viral illness
21 sridevi 6 Female 6 4100 39.5 1619.5 61.3 0.5-2.0 Negative Negative 1 Viral illness
22 tamilarasi 11 Female 7 15900 65 10335 109.7 < 0.5 Negative Negative 3 Viral illness
23 pratap kumar 5 Male 10 30000 80.5 24150 116.7 < 0.5 Negative Negative 5 Viral illness
24 dharanidharan 6 Male 7 7000 68.6 4802 21.8 < 0.5 Positive Negative 7
Bacterial
illness
25  rajesh kumar 11 Male 2 4800 54.7 2625.6 6.9 0.5-2.0 Negative Negative 1 Viral illness
26 bhuvaneswaran 5 Male 5 4000 19.6 784 1.7 2.1-10 Negative Negative 1 Viral illness
27 monica 1 Female 5 7900 46.4 3665.6 14.2 < 0.5 Negative Negative 3 Viral illness
28 kavinesh 4 Male 3 13000 47.3 6149 19.2 < 0.5 Negative Negative 4 Viral illness
29 vignesh 10 Male 7 12340 56.4 6959.76 15.3 < 0.5 Negative Negative 3 Viral illness
30 joanna maria 5 Female 3 6800 65.3 4440.4 56.3 2.1-10 Positive Negative 6
Bacterial
illness
31 sai karthikeyan 1 Male 5 12200 73.4 8954.8 45.3 < 0.5 Negative Negative 3 Viral illness
32 muthukumar 2 Male 4 9800 60 5880 10 < 0.5 Negative Negative 3 Viral illness
33 malar 4 Female 5 5600 68.3 3824.8 23.3 0.5-2.0 Negative Positive 5
Bacterial
illness
34 senthil murugan 6 Male 3 12000 34.3 4116 12.2 2.1-10 Negative Negative 3 Viral illness
35 sumathi b/o 1 Male 2 10200 43.3 4416.6 12 < 0.5 Negative Negative 4 Viral illness
36 preethi 6 Female 5 5600 65.3 3656.8 12.3 0.5-2.0 Negative Negative 4 Viral illness
37 mahalakshmi 9 Female 4 7800 45.6 3556.8 9.7 < 0.5 Negative Negative 2 Viral illness
38 akshaya 5 Female 1 10200 78.3 7986.6 34.3 0.5-2.0 Positive Negative 6
Bacterial
illness
39 suganthi 3 Female 1 12000 45.2 5424 12.3 0.5-2.0 Negative Negative 4 Viral illness
40 subbulakshmi 3 Female 4 9800 45.1 4419.8 23.2 < 0.5 Negative Negative 3 Viral illness
41 mohanashri 1 Female 2 10200 54.8 5589.6 18 < 0.5 Negative Negative 4 Viral illness
42 sriman 3 Male 4 12300 23 2829 9.2 < 0.5 Negative Negative 3 Viral illness
43 sanjay 11 Male 2 10200 45.3 4620.6 11.5 < 0.5 Negative Negative 4 Viral illness
44 yaazhni 4 Female 1 6900 34.3 2366.7 9.8 < 0.5 Negative Negative 3 Viral illness
45 ancy jeshni 1 Female 5 10300 54.3 5592.9 10.2 2.1-10 Negative Positive 2
Bacterial
illness
46 loganathan 10 Male 1 9800 23.2 2273.6 13.2 < 0.5 Negative Negative 4 Viral illness
47 sai raj 4 Male 4 9800 78.3 7673.4 16.4 < 0.5 Negative Negative 4 Viral illness
48 sriram 5 Male 3 10200 45.3 4620.6 20.1 < 0.5 Negative Negative 5 Viral illness
49 shyam 6 Male 3 5600 78.3 4384.8 56.3 2.1-10 Positive Negative 5
Bacterial
illness
50 vikesh 4 Male 3 12890 23.2 2990.48 34.3 < 0.5 Negative Negative 5 Viral illness
51 kishore 5 Male 3 8900 45.4 4040.6 12.9 < 0.5 Negative Negative 4 Viral illness
52 sunil kumar 8 Male 2 11200 34.3 3841.6 34.2 < 0.5 Negative Negative 4 Viral illness
53 parameshwari 5 Male 2 7800 54.3 4235.4 10.8 < 0.5 Negative Negative 3 Viral illness
54 lakshanethra 1 Female 5 6900 23.2 1600.8 9.3 < 0.5 Negative Negative 3 Viral illness
55 yuvaraj 12 Male 3 8900 34.4 3061.6 23.2 < 0.5 Negative Negative 3 Viral illness
56 guruprasad 7 Male 1 7800 56.4 4399.2 18.3 < 0.5 Negative Negative 4 Viral illness
57 nithish raj 7 Male 4 11200 45.3 5073.6 19.2 < 0.5 Negative Negative 2 Viral illness
58 madhan 5 Male 3 12200 67.3 8210.6 67.4 < 0.5 Negative Negative 4 Viral illness
59 monisha 9 Female 2 5600 23.3 1304.8 23.2 < 0.5 Negative Negative 7
Bacterial
illness
60 sabir basha 12 Male 7 13400 54.3 7276.2 13.3 < 0.5 Negative Negative 4
Bacterial
illness
61 jothika 7 Female 3 10200 34.3 3498.6 23.5 < 0.5 Negative Negative 6 Viral illness
62 monica 11 Female 4 11300 56.4 6373.2 34.2 < 0.5 Negative Negative 4 Viral illness
63 pavan raj 5 Male 4 9800 67.3 6595.4 13.7 < 0.5 Negative Negative 3 Viral illness
64 yogesh 11 Male 3 7600 54.2 4119.2 23.3 < 0.5 Negative Negative 4 Viral illness
65 tharish 4 Male 5 9800 63.2 6193.6 45.3 0.5-2.0 Negative Positive 5
Bacterial
illness
66 naresh 7 Male 2 9800 56.4 5527.2 22.1 < 0.5 Negative Negative 3 Viral illness
67 sheebha subhashini 10 Female 5 10200 34.3 3498.6 18.9 < 0.5 Negative Negative 2 Viral illness
68 rohini 12 Female 3 14300 72.1 10310.3 23.1 0.5-2.0 Positive Negative 5
Bacterial
illness
69 keerthana 11 Female 6 6700 45.3 3035.1 10 < 0.5 Negative Negative 1 Viral illness
70 chinthana 4 Female 3 9800 54.3 5321.4 10 < 0.5 Negative Negative 4 Viral illness
71 nithish 1 Male 2 4500 42.3 1903.5 10 < 0.5 Negative Negative 4 Viral illness
72 vignesh 10 Male 4 8900 59.3 5277.7 10 < 0.5 Negative Negative 3 Viral illness
73 mukesh 5 Male 1 3900 52.2 2035.8 2.1 0.5-2.0 Negative Negative 3 Viral illness
74 santhosh 2 Male 3 9900 57.3 5672.7 1.5 < 0.5 Negative Negative 3 Viral illness
75 yashwanth 2 Male 4 6700 67.6 4529.2 23.2 2.1-10 Positive Negative 5
Bacterial
illness
76 rohini 12 Female 3 9800 34.4 3371.2 27.1 < 0.5 Negative Negative 5 Viral illness
77 tharun 6 Male 4 8900 67.2 5980.8 17.1 < 0.5 Negative Negative 3 Viral illness
78 lokesh 12 Male 5 10800 23.2 2505.6 9.9 < 0.5 Negative Negative 4 Viral illness
79 sivaprakash 2 Male 3 8900 56.4 5019.6 8.9 < 0.5 Negative Negative 3 Viral illness
80 sadhana 1 Female 4 7800 23.2 1809.6 43.3 < 0.5 Negative Negative 4 Viral illness
81 adhi sankaran 3 Male 2 13400 67.4 9031.6 67.4 0.5-2.0 Negative Negative 5
Bacterial
illness
82 vetrivel murugan 10 Male 5 8900 56.4 5019.6 23.2 0.5-2.0 Positive Negative 5
Bacterial
illness
83 sanjai 3 Male 3 9800 72.2 7075.6 12.2 < 0.5 Negative Negative 4 Viral illness
84 sabari 3 Male 2 6700 16.2 1085.4 34.2 < 0.5 Negative Negative 3 Viral illness
85 harish 12 Male 4 7600 65.4 4970.4 12.3 < 0.5 Negative Negative 4 Viral illness
86 adhi sankaran 3 Male 3 12700 76.4 9702.8 32.2 < 0.5 Negative Positive 4
Bacterial
illness
87 abhinaya 1 Female 1 9700 45.3 4394.1 15.3 < 0.5 Negative Negative 5 Viral illness
88 rakesh 10 Male 1 9800 34.3 3361.4 30.2 < 0.5 Negative Negative 4 Viral illness
89 dhaswanth 1 Male 2 7800 23.2 1809.6 34.2 < 0.5 Negative Negative 4 Viral illness
90 dharshini 4 Female 14 10200 13.5 1377 13.2 < 0.5 Negative Negative 3 Viral illness
91 kameshwaran 10 Male 3 6700 35.2 2358.4 23.2 < 0.5 Negative Negative 2 Viral illness
92 monica 4 Female 5 8700 34.2 2975.4 13.2 < 0.5 Negative Negative 5 Viral illness
93 tamil selvi 4 Female 4 10400 34.1 3546.4 24 < 0.5 Negative Negative 6 Viral illness
94 ligiv 12 Female 10 4000 41.5 1660 1 < 0.5 Negative Negative 2 Viral illness
95 gokulnath 2 Male 2 11800 76.3 9003.4 45.6 2.1-10 Negative Negative 2 Viral illness
96 sangeetha 1 Female 3 8200 60 4920 10 < 0.5 Negative Negative 3 Viral illness
97 sivasakthi 5 Male 10 7900 33 2607 25.9 < 0.5 Negative Negative 3 Viral illness
98 swetha 5 Female 6 6100 77 4697 1.5 < 0.5 Negative Negative 3 Viral illness
99 nancy leena 1 Female 2 15600 91 14196 22.1 0.5-2.0 Negative Negative 2 Viral illness
100 kavitha 11 Female 2 6600 51.3 3385.8 4 < 0.5 Negative Negative 2 Viral illness
101 bhuvaneswaran 11 Male 2 9100 33.9 3084.9 0.5 < 0.5 Negative Negative 2 Viral illness
102 deepak shiva 7 Male 2 10400 78.6 8174.4 16.6 0.5-2.0 Negative Negative 7
Bacterial
illness
103 jayanthi 12 Female 7 4000 43.6 1744 14.5 < 0.5 Positive Negative 7
Bacterial
illness
104 santhosh kumar 10 Male 4 4700 68.6 3224.2 2.5 < 0.5 Negative Negative 3 Viral illness
105 sutheeshwaran 2 Male 7 3500 35.2 1232 2.2 < 0.5 Negative Negative 3 Viral illness
106 sakthivel 1 Male 4 10200 15.9 1621.8 8.9 0.5-2.0 Negative Positive 4
Bacterial
illness
107 pradeep 3 Male 4 13000 66.4 8632 45.6 0.5-2.0 Negative Negative 2
Bacterial
illness
108 srilekha 1 Female 7 13000 30 3900 18.8 < 0.5 Negative Negative 2 Viral illness
109 bharath 3 Male 3 7100 73.4 5211.4 2.2 0.5-2.0 Negative Negative 2 Viral illness
110 pooja 4 Female 30 20100 59 11859 2.1 < 0.5 Negative Negative 3 Viral illness
111 dhanya shri 2 Female 14 8200 28.1 2304.2 0.7 < 0.5 Negative Negative 3 Viral illness
112 sanjay 7 Male 2 7200 48.2 3470.4 4.5 < 0.5 Negative Negative 2 Viral illness
113 kesav kumar 6 Male 7 11400 57.6 6566.4 20.6 0.5-2.0 Negative Negative 4 Viral illness
114 narmadha devi 11 Female 7 4000 45.1 1804 2.7 < 0.5 Negative Negative 6
Bacterial
illness
115 adithiya 8 Male 11 12000 32.8 3936 0.5 < 0.5 Negative Negative 3 Viral illness
116 jayaram 3 Male 3 12000 43.2 5184 39.1 0.5-2.0 Negative Positive 5
Bacterial
illness
117 hariharan 8 Male 4 27000 58.8 15876 155.5 0.5-2.0 Negative Negative 2
Bacterial
illness
118 sharmila 7 Female 10 20600 76.7 15800.2 36.3 0.5-2.0 Negative Negative 3 Viral illness
119 sankar 4 Male 5 4000 50.2 2008 1.6 < 0.5 Negative Negative 2 Viral illness
120 yogeshwaran 1 Male 2 6900 43.5 3001.5 21.3 < 0.5 Negative Negative 2 Viral illness
121 yogesh 2 Male 3 8200 51.9 4255.8 1.4 < 0.5 Negative Negative 3 Viral illness
122 maria yashini 2 Female 2 10100 60.8 6140.8 6.3 0.5-2.0 Negative Negative 4 Viral illness
123 gayathiri devi 4 Female 3 12000 61.2 7344 9.3 < 0.5 Negative Negative 3 Viral illness
124 jagan 1 Male 2 12800 57.8 7398.4 36.2 0.5-2.0 Negative Negative 2 Viral illness
125 srikanth 7 Male 2 9700 57.6 5587.2 13.2 0.5-2.0 Negative Negative 2 Viral illness
126 parameshkumar 1 Male 5 15400 54 8316 78.1 0.5-2.0 Negative Negative 4 Viral illness
127 gracy 1 Female 5 13800 78.8 10874.4 13.8 < 0.5 Negative Negative 3
Bacterial
illness
128 dinesh 4 Male 5 12000 64.8 7776 0.8 < 0.5 Negative Negative 4 Viral illness
129 jaikishore 4 Male 7 12800 42.4 5427.2 2 < 0.5 Negative Negative 2 Viral illness
130 tamil 12 Male 4 8200 60 4920 0.8 < 0.5 Negative Negative 5 Viral illness
131 tamilselvi 4 Female 2 12500 82.2 10275 4.9 < 0.5 Negative Negative 2 Viral illness
132 kamesh ananthan 1 Male 2 7300 42.7 3117.1 24.4 < 0.5 Negative Negative 3 Viral illness
133 ameena yasmin 3 Female 5 6800 21.7 1475.6 1.4 < 0.5 Negative Negative 3 Viral illness
134 dharun 2 Male 2 16700 5 835 27.6 < 0.5 Negative Negative 5 Viral illness
135 prassana 4 Male 3 9300 64.3 5979.9 26 0.5-2.0 Negative Negative 5 Viral illness
136 nithiya 8 Female 7 9000 42.1 3789 31.2 < 0.5 Negative Negative 2 Viral illness
137 kamesh suresh 8 Male 3 3600 36.1 1299.6 5.1 0.5-2.0 Negative Negative 3
Bacterial
illness
138 monish 4 Male 4 12200 83.3 10162.6 1.4 0.5-2.0 Negative Negative 2 Viral illness
139 dhanshika 2 Female 5 11200 63.3 7089.6 125 < 0.5 Negative Negative 3 Viral illness
140 kaviraj 2 Male 7 9600 35.7 3427.2 11.5 0.5-2.0 Negative Negative 3 Viral illness
141 suriya varman 11 Male 3 7300 40.5 2956.5 10 < 0.5 Negative Negative 3 Viral illness
142 pramila 5 Female 3 11800 85.2 10053.6 63.3 0.5-2.0 Negative Negative 3
Bacterial
illness
143 siddarthan 3 Male 4 10200 41.2 4202.4 18.3 < 0.5 Negative Negative 4 Viral illness
144 sughasini 4 Female 4 9800 48.9 4792.2 0.5 < 0.5 Negative Negative 3 Viral illness
145 hemanth 11 Female 6 11000 67.7 7447 45.6 0.5-2.0 Negative Negative 2
Bacterial
illness
146 akash 4 Male 7 7900 63.4 5008.6 12 0.5-2.0 Negative Negative 4
Bacterial
illness
148 abinesh 3 Male 7 11600 37.4 4338.4 35.2 2.1-10 Positive Negative 5
Bacterial
illness
147 dhanush kumar 4 Male 14 15200 33 5016 10 < 0.5 Negative Negative 4 Viral illness
149 vishnal 7 Male 7 5200 52.3 2719.6 86.2 < 0.5 Negative Negative 5 Viral illness
150 jenifer 8 Female 4 14000 38.3 5362 10 < 0.5 Negative Negative 3 Viral illness
151 yuvaraj 9 Male 3 5900 47 2773 14.7 < 0.5 Positive Negative 4
Bacterial
illness
152 abishek 3 Male 10 13400 27.4 3671.6 19.5 0.5-2.0 Negative Negative 10 Viral illness
153 giridharan 4 Male 20 9300 43.2 4017.6 10.5 < 0.5 Negative Negative 2 Viral illness
154 kamalesh 6 Male 10 8900 43.2 3844.8 24.1 < 0.5 Negative Negative 5 Viral illness
155 sasvitha sri 6 Female 10 12200 15 1830 26 < 0.5 Negative Negative 5 Viral illness
156 rituvarshini 2 Female 4 7900 45.3 3578.7 10.2 < 0.5 Negative Negative 5 Viral illness
157 aathira 3 Female 3 13200 63.2 8342.4 34.2 0.5-2.0 Negative Positive 6
Bacterial
illness
158 megala 5 Female 2 6500 65.3 4244.5 6.3 < 0.5 Negative Negative 2 Viral illness
159 vijayranjan 4 Male 4 5600 34.2 1915.2 12.2 < 0.5 Negative Negative 4 Viral illness
160 mirthula 1 Female 3 13200 54.3 7167.6 8.9 < 0.5 Negative Negative 3 Viral illness
161 rohith 5 Male 4 12000 56.3 6756 12.2 < 0.5 Negative Negative 3 Viral illness
162 yaswanth 12 Male 2 8700 34.3 2984.1 6.4 < 0.5 Negative Negative 2 Viral illness
163 subiksha 1 Female 3 4500 67 3015 18.3 < 0.5 Negative Negative 1 Viral illness
164 eshwanth 5 Male 3 75000 52 39000 12.4 < 0.5 Negative Negative 4 Viral illness
165 nithish 1 Male 2 6700 47.4 3175.8 9 < 0.5 Negative Negative 2 Viral illness
166 sandhya 8 Female 5 8600 34.2 2941.2 7.9 < 0.5 Negative Negative 3 Viral illness
167 karthika 6 Female 4 12900 23.2 2992.8 12.2 0.5-2.0 Negative Negative 4 Viral illness
168 monica poongodi 1 Female 3 9200 65.4 6016.8 10 < 0.5 Negative Negative 4 Viral illness
169 roopashree 5 Female 5 15300 78.2 11964.6 12.2 0.5-2.0 Negative Positive 6
Bacterial
illness
170 archana 10 Female 2 16200 77.2 12506.4 45.3 0.5-2.0 Positive Negative 5
Bacterial
illness
171 hussaini m 7 Female 4 6700 40.6 2720.2 23.2 < 0.5 Negative Negative 4 Viral illness
172 hariharan 5 Male 3 7600 23.3 1770.8 14.4 < 0.5 Negative Negative 1 Viral illness
173 samiksha 1 Female 1 9800 56.3 5517.4 16.3 < 0.5 Negative Negative 3 Viral illness
174 rohith 6 Male 4 10500 62.2 6531 13.4 < 0.5 Negative Negative 2 Viral illness
175 sree devi 7 Female 4 8300 23.4 1942.2 9.6 < 0.5 Negative Negative 4 Viral illness
176 rithish 5 Male 4 6900 35.3 2435.7 8.4 < 0.5 Negative Negative 3 Viral illness
177 alan vino 8 Male 3 7600 34.4 2614.4 11.4 < 0.5 Negative Negative 3 Viral illness
178 hemapriya 2 Male 5 6800 45.3 3080.4 19 < 0.5 Negative Negative 4 Viral illness
179 naveen 3 Male 1 21000 83.2 17472 56.3 0.5-2.0 Positive Negative 9
Bacterial
illness
180 saravanan 2 Male 2 9800 43.2 4233.6 12.2 < 0.5 Negative Negative 3 Viral illness
181 gomathi 8 Female 3 12400 58.9 7303.6 9.9 < 0.5 Positive Negative 6
Bacterial
illness
182 akshay 2 Male 2 5900 67.4 3976.6 8.9 < 0.5 Negative Negative 3 Viral illness
183 karthikeyan 7 Male 4 14300 61.1 8737.3 12.1 < 0.5 Positive Negative 4
Bacterial
illness
184 ashwin kumar 4 Male 3 4800 58.3 2798.4 15 < 0.5 Positive Negative 5
Bacterial
illness
185 akshyashree 1 Female 4 6400 64.8 4147.2 13.5 < 0.5 Negative Negative 3 Viral illness
186 roseline 8 Female 4 6100 75.5 4605.5 23.6 < 0.5 Positive Negative 3
Bacterial
illness
187 vidhyashri 4 Female 3 8500 43.5 3697.5 19.7 < 0.5 Negative Negative 3 Viral illness
188 dhanusy 10 Male 2 5900 78.9 4655.1 34.3 0.5-2.0 Negative Negative 3 Viral illness
189 dhanushya 10 Female 2 10200 56.3 5742.6 29.8 0.5-2.0 Negative Negative 3 Viral illness
190 vignesh 11 Male 3 7400 62.1 4595.4 10 0.5-2.0 Positive Negative 4
Bacterial
illness
191 john abraham 5 Male 4 8700 45.4 3949.8 10 < 0.5 Negative Negative 4 Viral illness
192 sharmila 5 Female 3 12400 56.3 6981.2 10 < 0.5 Negative Negative 3 Viral illness
193 manoj 6 Male 2 6400 49.3 3155.2 10 < 0.5 Negative Negative 4 Viral illness
194 tanush 2 Male 1 9800 52.1 5105.8 10 < 0.5 Negative Negative 3 Viral illness
195 velan 8 Male 5 7800 44.4 3463.2 10 0.5-2.0 Positive Negative 5
Bacterial
illness
196 vijaya kumar 10 Male 3 3400 38.3 1302.2 31.1 0.5-2.0 Positive Negative 4
Bacterial
illness
197 jayashree 6 Female 4 8300 71.2 5909.6 21.2 0.5-2.0 Positive Negative 4
Bacterial
illness
198 santhosh kumar 5 Male 3 9300 43.3 4026.9 8.4 < 0.5 Negative Negative 3 Viral illness
199 jaichandran 2 Male 2 10200 34.2 3488.4 5 < 0.5 Negative Negative 4 Viral illness
200 soundarya 9 Female 5 7500 54.4 4080 10.3 < 0.5 Negative Negative 3 Viral illness
201 anandh 10 Male 3 15200 85.2 12950.4 121.2 2.1-10 Negative Negative 3 Viral illness
202 saraswathy 8 Female 3 18000 79.2 14256 65.3 0.5-2.0 Negative Negative 4 Viral illness
203 sudharsan 6 Male 2 5600 48.2 2699.2 12.5 < 0.5 Negative Negative 5 Viral illness
204 keerthi rajan 3 Male 2 11400 67.2 7660.8 35.3 < 0.5 Negative Negative 4
Bacterial
illness
205 divya dharsini 8 Female 3 8400 71.2 5980.8 39.4 < 0.5 Negative Negative 4 Viral illness
206 arokiya angel vinisha 4 Female 4 7400 67.3 4980.2 19.2 < 0.5 Negative Negative 5
Bacterial
illness
207 laleb aria 5 Female 3 5600 45.3 2536.8 8 < 0.5 Negative Negative 3 Viral illness
208 kavinisha 4 Female 2 6200 54.8 3397.6 9.4 < 0.5 Negative Negative 5 Viral illness
209 karthick 5 Male 3 7300 23 1679 13.5 < 0.5 Negative Negative 6 Viral illness
210 baby sunitha 1 Female 1 9800 45.3 4439.4 20.3 < 0.5 Negative Negative 4 Viral illness
211 rajesh kumar 4 Male 4 10400 34.3 3567.2 19.4 < 0.5 Negative Negative 5 Viral illness
212 suresh raju 2 Male 1 11100 54.3 6027.3 15.3 < 0.5 Negative Negative 3 Viral illness
213 ugendran 6 Male 3 6800 23.2 1577.6 9.7 < 0.5 Negative Negative 5 Viral illness
214 kanishka 3 Female 2 9300 78.3 7281.9 20.2 0.5-2.0 Negative Positive 3
Bacterial
illness
215 mohana 4 Female 4 5600 45.3 2536.8 17.2 < 0.5 Negative Negative 5 Viral illness
216 eashwar baby 2 Male 3 9500 78.3 7438.5 10.8 < 0.5 Negative Negative 3 Viral illness
217 lakshmi sree 10 Female 3 8700 23.2 2018.4 15.3 < 0.5 Negative Negative 5 Viral illness
218 ramya 2 Female 4 9400 45.4 4267.6 8.3 < 0.5 Negative Negative 3 Viral illness
219 ramakrishnan 7 Male 3 4500 34.3 1543.5 16.5 0.5-2.0 Positive Negative 5
Bacterial
illness
220 kesavarthini 1 Female 2 7200 54.3 3909.6 5 < 0.5 Negative Negative 3 Viral illness
221 shakin 4 Female 9 2100 23.2 487.2 17.3 0.5-2.0 Negative Negative 3 Viral illness
222 nikitesh 3 Male 3 4800 40.6 1948.8 15.3 < 0.5 Negative Negative 5 Viral illness
223 jeyan 3 Male 2 52000 23.3 12116 22.3 < 0.5 Negative Negative 3 Viral illness
224 dulasidharan 9 Male 4 7300 56.3 4109.9 17.4 < 0.5 Negative Negative 4 Viral illness
225 sankar 4 Male 3 9800 62.2 6095.6 30.2 < 0.5 Negative Negative 5 Viral illness
226 vijayan 7 Male 4 11500 23.4 2691 9.4 0.5-2.0 Negative Negative 4 Viral illness
227 tamilarasi 4 Male 3 13200 35.3 4659.6 13.5 < 0.5 Negative Negative 3 Viral illness
228 jayaram 10 Male 3 14200 34.4 4884.8 25.3 0.5-2.0 Positive Negative 5
Bacterial
illness
229 ramesh 3 Male 4 8700 45.3 3941.1 23.2 < 0.5 Negative Negative 3 Viral illness
230 ashwini 5 Female 2 6800 58.8 3998.4 34.6 < 0.5 Positive Negative 6
Bacterial
illness
231 satheeshwaran 4 Male 2 5600 76.7 4295.2 8 < 0.5 Negative Negative 4 Viral illness
232 durai raj 8 Male 3 4800 50.2 2409.6 6.5 < 0.5 Negative Negative 4 Viral illness
233 sridharan 4 Male 2 4300 43.5 1870.5 5.3 < 0.5 Negative Negative 3 Viral illness
234 wilson 6 Male 3 9400 51.9 4878.6 14.3 < 0.5 Negative Negative 3 Viral illness
235 nazrudeen 5 Male 2 7800 60.8 4742.4 18.8 < 0.5 Negative Negative 4 Viral illness
236 hemaroshini 3 Female 3 8700 44.3 3854.1 7.8 < 0.5 Negative Negative 5 Viral illness
237 ramya 4 Female 3 8400 57.8 4855.2 17.3 < 0.5 Negative Negative 4 Viral illness
238 saravanan 3 Male 2 7600 57.6 4377.6 22.5 0.5-2.0 Negative Negative 3 Viral illness
239 lakshanashree 2 Female 4 5600 54 3024 10.9 < 0.5 Negative Negative 4 Viral illness
240 gnanasekaran 5 Male 3 11200 78.8 8825.6 12.4 < 0.5 Negative Negative 3 Viral illness
241 shakin 4 Female 4 2700 64.8 1749.6 15.7 2.1-10 Negative Negative 9 Viral illness
242 madhumari 5 Male 3 9500 42.4 4028 32.2 2.1-10 Positive Negative 6
Bacterial
illness
243 praveen 4 Male 3 13200 60 7920 33.2 < 0.5 Negative Negative 4
Bacterial
illness
244 samuel 4 Male 4 12300 82.2 10110.6 29.9 0.5-2.0 Positive Negative 5 Bacterial
illness
245 sharik 3 Male 2 10500 42.7 4483.5 6.3 < 0.5 Negative Negative 4 Viral illness
246 abinaya 4 Female 2 12400 21.7 2690.8 14.3 < 0.5 Negative Negative 4 Viral illness
247 vishal 7 Male 4 9430 5 471.5 22.5 < 0.5 Negative Negative 4 Viral illness
248 xena 6 Female 3 8940 64.3 5748.42 34.2 2.1-10 Negative Negative 3 Viral illness
249 nivetha 6 Female 3 7890 42.1 3321.69 12.6 < 0.5 Negative Negative 3 Viral illness
250 sanjay 3 Male 4 4390 56.3 2471.57 7 < 0.5 Negative Negative 4 Viral illness
251 preethika 2 Female 4 10200 54.3 5538.6 33.2 < 0.5 Negative Negative 3 Viral illness
252 sathya 5 Female 3 14200 61.2 8690.4 30.2 < 0.5 Negative Negative 4 Viral illness
253 gokulakrishnan 8 Male 2 6700 55.5 3718.5 23.4 < 0.5 Negative Negative 3 Viral illness
254 malarvanan 5 Male 3 4800 71.2 3417.6 45.6 < 0.5 Negative Negative 4 Viral illness
255 siva subha 5 Female 2 6700 61.2 4100.4 7.3 < 0.5 Negative Negative 3 Viral illness
256 karthick 11 Male 3 8700 56.2 4889.4 14.5 < 0.5 Negative Negative 4 Viral illness
257 stenthiramenon 1 Female 3 9300 39.2 3645.6 12.2 < 0.5 Negative Negative 4 Viral illness
258 jonatha leoni 3 Female 4 10200 44.3 4518.6 15.3 0.5-2.0 Negative Negative 3 Viral illness
